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Chapter 1. Introduction 
1.1. Strategies for nucleic acid modification 
The field of biological and biomedical research relies heavily on strategies for biomolecular 
modification in order to label and expand the functional potential of the target structure. The 
development of methods for DNA and RNA tailoring is a key step not only to understand their 
biological role, but also to perturb their function for diagnostic and therapeutic use. The number of 
labels per oligonucleotide molecule and their exact location depends strongly on the respective 
application. In some examples for fluorescent in situ hybridization (FISH) oligonucleotides with only 
a single fluorescent label are used.1 The construction of molecular beacons for real-time PCR2,3 and 
cassette-labeled primers for DNA-sequencing4 requires at least one donor/acceptor pair (two 
modifications) per DNA molecule, with a precisely defined distance in between for proper 
fluorescence quenching in the former case and efficient fluorescence enhancement in the latter. There 
are also cases where densely functionalized nucleic acids are needed, often with several contiguous 
modified bases, like some DNA architectures for biomedical and nanotechnology applications.5,6,7  
Such decorated DNAs and RNAs can be accessed by two general strategies. The modifications can be 
introduced pre-synthetically by using modified monomers for the nucleic acid assembly or post-
synthetically by directly modifying the target DNA or RNA molecules. 
 
1.1.1. Pre-synthetic approaches for nucleic acid modification  
The nucleic acid assembly itself can be done in a number of ways. The most widely used chemical 
approach for the preparation of short and medium-sized oligonucleotides (up to 200 bases) is the 
automated oligonucleotide solid-phase synthesis (OSPS) using phosphoramidite chemistry.8 An 
outline of the method is presented in Scheme 1. The first monomer enters the cycle already attached to 
the solid support (Scheme 1, a). It is then detritylated under acidic conditions to reveal the 5′-OH 
group of the growing chain (b). The second monomer unit is added by coupling the respective 
phosphoramidite c after activation with a weak acid (tetrazole). This is followed by oxidation of the 
phosphonium species d to a phosphonate e, and capping the unreacted 5′-OH groups in order to avoid 
elongation of failure chains. Any truncated products f will not react any further and are effectively 
removed from the synthetic cycle. Intermediate e can either be subjected to second coupling cycle or 
cleaved from the solid support and deprotected under basic conditions to afford the final product g. By 
this method the monomer units are joined in a step-wise fashion, elongating the newly-formed chain in 
a 3′-5′ direction and a modification can be introduced at a specified position by the use of the 
respective tailored phosphoramidite precursor. PCR, chain extension and ligation are the main 
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enzymatic approaches for incorporation of pre-synthetically modified monomers into DNA, in this 
case NTPs.6,7,9,10,11,12  
 
 
Scheme 1│Oligonucleotide solid-phase synthesis. (1) Detritylation with dichloroacetic acid in DCM reveals the 5′-hydroxyl 
group of the growing chain. (2) The 5′-O-protected-3′-phosphoramidite monomer is coupled to the 5′-hydroxyl group of the 
growing chain after protonation by tetrazole. (3) The phosphonium species d is oxidized to the phosphonate e. (4) Unreacted 
5′-hydroxyl groups are ‘capped’ with an acylating reagent to prevent them from further reacting in subsequent coupling 
cycles. The growing chain can either be subjected to a second cycle of elongation (detritylation, coupling, etc.) or cleaved 
and deprotected under aqueous basic conditions (most often 32 % (v/v) ammonia in water for DNA or ammonia-ethanol for 
RNA) to afford the final product (5). 
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They are often unable to promote efficient coupling of some sterically demanding substrates, but are 
particularly valuable for preparation of longer DNAs. Two examples of modified monomers for 
introduction of an alkyne function in DNA - a phosphoramidite for OSPS (a) and a nucleoside 
triphosphate for PCR (b) - are shown below.  
 
The preparation of modified RNAs is a far more complex task due to the greater susceptibility of the 
RNA molecules to chemical damage and enzymatic degradation, as well as the limited chain lengths (a 
little over a hundred bases) that can be accessed by OSPS.13 Such cases often necessitate the use of 
more complex multistep synthetic strategies. 
The label itself can be placed either terminally, at the 3′- or 5′-end hydroxyl groups, or inside the 
nucleic acid strand. In principle, an internal modification can be introduced at the phosphate backbone, 
on the ribose or on the nucleobase. One example of a phosphate modification is the introduction of 
multiple fluorophores on a phosphorothioate DNA as described by Conway and McLaughlin (Scheme 
2a).14 This approach, however, is not commonly utilized, since it perturbs the helix conformation and 
duplex stability, and interferes with most enzymatic reactions.15  
Functionalization of the ribose 2′-hydroxyl group has proven fruitful for label attachment in several 
cases, as substitution at that site does not greatly affect the duplex stability. This strategy was used by 
Wagenknecht et al. to introduce an alkyne function for ‘click’ chemistry attachment of azide dyes 
(Scheme 2b),16 and by the group of Yamana for preparation of a 2′-intercalator-labeled detection 
system specific for RNA (Scheme 2c).17  
 
Scheme 2│Modifications on the phosphate (a) and the 2′-hydroxyl group of the ribose ring (b, c). 
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When functionalizing the nucleobase in pyrimidine analogues C-5 is the preferred position for 
introduction of the modification, as it does not take part in Watson-Crick interactions and fits well in 
the major groove of the double helix with stabilities of the modified duplexes almost identical to those 
of the non-modified counterparts (Scheme 3a and b).6,10  
Modifications on the purine bases, e.g. at C-8 (Scheme 3c), are generally avoided, as they disturb the 
overall stability of the double helix. When DNA polymerases are used for their incorporation such 
modification can interfere with their activity and significantly decrease the labeling efficiency.10,11 The 
use of certain analogues, such as modified at C-7 7-deazaadenine (Scheme 3d), could alleviate this 
problem.18                
 
Scheme 3│Modification on the nucleobases: C-5 in pyrimidine analogues (a, b), C-8 in adenine (c), and C-7 in 7-
deazaadenine (d) 
 
1.1.1.1. Chemical approaches for pre-synthetic nucleic acid modification 
 
Oligonucleotide chemical synthesis is in principle quite flexible concerning the modifying group steric 
bulk and provides an access to a broader variety of attached tags than the enzymatic methods. It also 
allows the use of monomers that are considerably different than the natural nucleosides. Scheme 4 
illustrates several examples for commercially available monomer units for the introduction of a biotin 
moiety by OSPS. In example a the tag is introduced at the C-5 of a thymine base through a hexyl 
diamine spacer arm. The tert-butylbenzoyl protecting group on the biotin is removed during the 
ammonium hydroxide deprotection step. Derivatives b and c are examples of non-nucleoside 
phosphoramidite monomers with different length and polarity of the biotin spacer, both suited for 
intrastrand incorporation. Example d is termed for 5′-termination, as it lacks a DMT-protected primary 
hydroxyl group for further chain elongation. The derivative in example e is used for 3′-labeling, as it is 
directly attached to the solid support. Removal of the DMT-group reveals a free primary hydroxyl 
group for attachment of the next unit.  
A particularly important group of labels are different dye molecules – fluorophores and quenchers 
(Scheme 5). As discussed earlier they have a variety of practical applications and can be readily 
introduced by direct attachment to the respective monomers for oligonucleotide synthesis. 
Fluorescein-based dyes (a) are one of the most widely used fluorescent tags. The respective 
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phosphoramidites for both 3′- and 5′-end labeling, as well as for internal incorporation are 
commercially available for most of them. A second group of fluorescent probes, the cyanine dyes (b), 
are used mainly for real-time PCR and FISH analysis19 and are introduced at one end of the chain, as 
internally they cause destabilization of the nucleic acid duplex. Rhodamine tags (c), used both as 
fluorophores and as quenchers, as well as dabcyl (d), and the Black Hole QuenchersTM (BHQTMs, e) 
are three other examples of commonly applied dye molecules. The BHQTMs have recently gain 
popularity, as they display high quenching efficiency and broad spectral overlap, which makes them 
suited for a number of advanced applications in modern genomics and diagnostics.     
 
Scheme 4│Examples for commercially available phosphoramidites for introduction of biotin moieties. 
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Scheme 5│Examples for commercially available dyes for direct introduction in OSPS. Fluorescein (a), Cyanine 540 (b), 
TAMRA (5-Carboxytetramethylrhodamine) (c), Dabcyl (d), and BHQ-1TM (e). 
A practical strategy to chemically introduce a variety of new functional groups into DNAs and RNAs 
is through monomers bearing a specific tag, which after OSPS and deprotection is used to further 
decorate the oligonucleotide molecule. Often discussed as a post-synthetic modification strategy,15 
such approach should rather be classified as a pre-synthetic method, since the primary modification 
handle is installed already before the assembly of the nucleic acid. Masked amino or thiol groups 
(Scheme 6), that after deprotection can be modified with suitable electrophilic reagents (4-nitrophenyl 
and N-hydroxysuccinimide esters, maleimides), are employed quite commonly.  
 
Scheme 6│Examples for commercially available phosphoramidites for introduction of nucleophilic groups for post-synthetic 
tagging. Masked 5′-terminal amino groups with acid-labile (a) and base-labile protection (b). Introduction of a thiol group 
protected as a disulfide (c). 
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The introduction of terminal alkynes for CuAAC is also a convenient approach for pre-synthetic 
chemical tagging. It has recently gained broad popularity due to the reliability and simplicity of the 
CuAAC and the compatibility of the alkyne and the azide groups used with a wide variety of 
biologically relevant functionalities. Besides the already discussed contributions from the Carrel5 and 
Wagenknecht16 groups, a particularly interesting example for pre-synthetic introduction of such tags 
comes from the group of Tom Brown, who have developed a ‘click’-able biocompatible linker for 
ligation of DNA strands.20 3′-Alkyne and 5′-azide terminated single-stranded DNAs, prepared by 
OSPS, have been efficiently ligated, affording products of up to 300 bases in length (Scheme 7). The 
products were read through with high fidelity during PCR providing the full-length amplicons. In 
addition, a gene containing the triazole linker was shown to be functional in E. coli cells. 
 
Scheme 7│A biocompatible triazole DNA-linker developed by Brown et al.20 Single-stranded DNA chains terminated by a 
3′-alkyne and 5′-azide, are efficiently ligated by CuAAC using a bridging DNA template (DNA splint). The triazole linker in 
the new chain used as a template for a PCR-amplification is read through correctly. 
 
1.1.1.2. Enzymatic and hemienzymatic approaches for pre-synthetic nucleic acid modification 
PCR and chain extension techniques with chemically tailored NTPs are the main enzymatic 
approaches for incorporation of modified nucleotides in DNA. Several examples from the Carrell 
group demonstrate the utility of the PCR method for the incorporation of alkyne-tagged monomers for 
subsequent tagging via CuAAC.6,7,12 DNA 3′-end labeling with terminal deoxynucleotidyl transferase 
(TdT) and fluorescently-tagged NTPs is an example for a chain-extension technique.21 TdT is a 
template-independent DNA polymerase that can extend a 3′-chain end with twenty to over a hundred 
bases. For some applications the attachment of just a single fluorophore per DNA molecule is required 
and in such cases a tagged ddNTP terminator is used.22 The efficiency of incorporation, however, 
depends strongly on the structure of the fluorescent moiety.23     
Direct enzymatic RNA 3′-end labeling can be done with poly(A) polymerase as described by Martin 
and Keller.24 They have demonstrated the addition of dNTPs and ddNTPs to RNA for formation of 
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homopolymer tracts on the 3′-end, as well as the efficient incorporation of biotin- and digoxigenin-
tagged NTPs (Scheme 8).  
 
Scheme 8│NTPs for introduction of biotin (a) and digoxygenin tag (b) by RNA 3′-end extension with poly(A) polymerase. 
As already mentioned modified RNAs are quite a difficult target due to their fragility. In many cases 
the preparation of more complex RNA molecules involves multi-step hemienzymatic (semisynthesis) 
approaches, where the target RNA is prepared by joining two or more previously generated segments 
(Scheme 9). In one such example, a short fragment bearing a modification (RNA-1) has been prepared 
by OSPS and then ligated with a larger enzymatically-generated fragment (RNA-2) using T4 DNA 
ligase and a complementary DNA template (splint) bridging the end sections of the two RNA 
fragments.25 
 
Scheme 9│Semisynthetic approach to modified RNAs: the shorter RNA-1 from OSPS bearing a modification is 
enzymatically ligated to a longer strand (RNA-2) using a DNA-splint 
A rather tedious synthetic scheme for internal RNA labeling has been worked out by the group of 
Jaeschke (Scheme 10).26 A 3′-end extension of an RNA fragment by poly(A) polymerase with a 2′-
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azidonucleoside-5′-triphosphate (a), followed by ligation of a second RNA to the new 3′-end (b) 
ultimately allowed the installation of an internal Alexa Fluor 647 tag by CuAAC (c).   
 
Scheme 10│General scheme for introduction of an internal label in RNA using a poly(A) polymerase (a), ligation to a 
second RNA chain (b), and CuAAC with a fluorescently-tagged alkyne (c).  
 
Modified RNAs can also be synthesized by using unnatural base pair systems. An unnatural base is 
installed on a DNA template and then used to direct the incorporation of a second unnatural base, 
uniquely complementary to it. An early example for this approach is the introduction of N6-(6-
aminohexyl)isoguanosine in RNA by specifically pairing it to 5-methylisocytosine in the DNA 
template (Scheme 11a).27 Hirao and co-workers have later expanded this methodology for the 
installation of fluorescent28 and biotin tags29 by pairing 2-amino-6-(2-thienyl)purine and 2-amino-6-(2-
thiazolyl)purine to the labeled 2-oxo(1H)pyridine base (Scheme 11b and c).   
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Scheme 11│Modified RNA synthesis by using unnatural base pairs: 5-methylisocytosine paired with N6-(6-
aminohexyl)isoguanosine (a), and 2-amino-6-(2-thienyl)purine or 2-amino-6-(2-thiazolyl)purine paired with 2-
oxo(1H)pyridine for introduction of fluorescent (b) and biotin tags (c). 
 
1.1.2. Post-synthetic approaches for nucleic acid modification 
The modification of already synthesized DNA and RNA molecules is intuitively more direct and 
should provide access to structures of a greater complexity, especially in terms of chain length. One of 
the very few and most important enzymatic techniques for post-synthetic DNA and RNA 
modification involves the use of methyltransferases. Methyltransferases (MTases) are enzymes 
catalyzing the highly specific transfer of methyl groups from the ubiquitous cofactor S-adenosyl-L-
methionine (AdoMet, Scheme 12A) to various positions in DNA or RNA (Scheme 12B). In the same 
manner MTase can operate with a variety of modified cofactors, allowing for sequence-specific DNA 
and RNA tagging.  
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Scheme 12│Nucleic acid methylation, catalyzed by MTases. Structure of the AdoMet cofactor (A); possible alkylation sites 
depending on the MTase specificity: N-6 of adenine, N-4 and C-5 of cytosine (B).   
The method was first established by the group of Weinhold for MTase from Thermus aquaticus 
(M.TaqI) and included substitution of the S-alkylmethionine moiety of the cofactor with an aziridine 
group for covalent attachment of the entire molecule to the target (Scheme 13A).30,31,32,33 It was 
applied for plasmid DNA labeling with dansyl30,31 and cyanine fluorophores,33 and biotin,32 installed 
on the cofactor’s adenine base (Scheme 13B). The approach was further developed by modification of 
the S-alkyl group on the methionine sulfur alone for group transfer without attachment of the entire 
cofactor (Scheme 14).34 Functionalization with terminal alkynes for example would allow further 
decoration of the target structure by using CuAAC, e.g. with fluorescent labels.35  
 
Scheme 13│Nucleic acid modification with an aziridine-modified cofactor. Mechanistic base: an attack by a nucleophile 
from the nucleic acid on one of the aziridine carbons leads to a ring opening and covalent attachment of the entire cofactor 
(A). Structure of modified cofactors for introduction of a dansyl (a), biotin (b), and a cyanine tag (c).   
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Scheme 14│Nucleic acid modification with a modified AdoMet cofactor, allowing sequence-specific group transfer. 
DNAs and RNAs can be post-synthetically modified by chemical approaches. In general, such 
approaches involve the use of activated electrophiles, which react with nucleophilic groups of the ribo-
phosphate backbone or the nucleobases. Implementation of simple SN1 and SN2 alkylating reagents 
like alkyl halides and nitrosoureas is usually avoided, except for some specific applications. The 
methods utilizing these reagents suffer from low selectivity and require large excesses of the 
alkylating reagent. They, however, are quite valuable for establishing the relative reactivity of the 
different nucleic acid elements towards electrophiles and have helped correlating the action of a 
variety of carcinogens with the nucleic acid damage caused.36 Mapping the potential alkylation sites 
can also assist the development of new DNA and RNA modification strategies by pointing out 
possible reaction targets.  
SN1 type alkylation reagents (N-methyl-N′-nitrosourea, N-methyl-N′-nitro-N-nitrosoguanidine) target 
O-6 in guanine, and to a lesser extent O-4 in thymine, as well as the backbone phosphates and N-3 of 
adenine and guanine (Scheme 15A).37 In contrast, SN2 alkylating reagents (dimethyl sulfate, 
methylmethane sulfonate and methyl iodide) attack almost only nitrogen nucleophiles, especially N-1, 
N-3 and N-7 of adenine in single-stranded DNAs, and N-1 of adenine and N-3 of cytosine in double-
stranded DNAs (Scheme 15B). It should be noted that N-7 of guanine is the primary target of both 
types of reagents, and is also the most frequently occurring nucleic acid alkylation damage found in 
double-stranded DNAs. 
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Scheme 15│DNA modification patterns with SN1 (A) and SN2 type alkylation reagents (B). 
In addition to the direct alkylation with strong electrophiles there are several milder approaches, 
allowing a certain degree of selectivity of the modification. One such technique is the 3′-phosphate 
alkylation. It was first developed for RNAs cleaved in the presence of Mn2+ and imidazole.38 Such 
cleavage leaves a 2′,3′-cyclic phosphate at the 3′-end of the RNA chain (Scheme 16A). The phosphate 
is then reacted with a labeled arylmethyl halide to yield the 3′-phosphate tagged RNA. The method 
was later extended to the 3′-phosphate modification of both DNA and RNA by using 
aryldiazomethane.39 Appropriate tailoring of the aryl moiety assures efficient introduction of the 
desired label at the nucleic acid 3′-end (Scheme 16B).  
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Scheme 16│ 3′-End phosphate labeling: modification of the 2′,3′-cyclic phosphate with an arylmethyl bromide (A),38 and 3′-
phosphate biotinilation with an aryldiazomethane derivative (B) 
A group of techniques with a broad utility are the methods for DNA cross-linking. Usually the cross-
linking probes consist of a complementary to the target DNA strand with an activatable functionality 
installed at a specific position. Hybridization of the two strands and activation of the probe delivers the 
modification to the target in a sequence-specific manner. One such technique is the DNA cross-linking 
by in situ furan oxidation demonstrated by the group of Madder.40,41,42,43 The furan moiety is installed 
inside the modifying chain, either at C-2′ on the backbone,40,41 or through an abasic site for optimal 
hybridization with the target chain (Scheme 17A).42,43 The furan oxidation can be carried out with N-
bromosuccinimide (Scheme 17B),40,41,42 or with singlet oxygen, generated with red light irradiation 
and methylene blue as a photosensitizer (Scheme 17C).43 A plausible mechanistic model for the 
reaction of the 4-oxo-enal formed from the furan oxidation with the complementary cytosine base of 
the target chain affording a stable cross-link product is outlined in Scheme 17D.  
 
Scheme 17│ Furan-oxidation triggered sequence-specific DNA cross-linking: optimized DNA monomer structures for 
introduction of the furan moiety (A), plausible mechanism of furan oxidation by N-bromosuccinimide (B) and singlet oxygen 
in aqueous medium (C), and cross-linking with a complementary cytosine base affording the stable cross-link product (D). 
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Another method for sequence-specific DNA cross-linking has been developed by the group of Rokita. 
Their initial studies have shown that chemical modification of simple deoxynucleosides and DNA can 
be achieved with in situ generated o-quinone methides.44 The reactive species is obtained from an O-
silyl protected o-bromomethylphenol in the presence of fluoride and is shown to react with 
nucleobases containing an exocyclic amino group - adenine, guanine and cytosine (Scheme 18).  
 
Scheme 18│ o-Quinone methide formation and possible reaction products with adenine, guanine and cytosine nucleobases 
For cross-link applications45 an analogous derivative was attached to the 5′-end of a carrier DNA, 
complementary to the target nucleic acid sequence. Upon treatment with fluoride the reactive quinone 
methide generated on the chain’s end forms a self-adduct with one of the nucleobases on the 
modifying strand (Scheme 19, a). Such adduct formation is suggested to be reversible and is in 
equilibrium with activated species b. Species b can in turn be attacked by a nucleobase on the strand 
and form back a or by an external nucleophile Nu and form species c. Once the target chain d is added 
DNA duplex e forms, which is in equilibrium with quinone methide f. Species f can engage in an 
intrastrand interaction affording intermediate e, or form a cross-link adduct g with full base pairing. In 
practice the formation of such cross-link product seems to be favored. That is probably due to the 
energy gain from the additional base pairing, which is the energetic barrier preventing the back-
formation of any constrained intermediates e.  
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Scheme 19│ DNA cross-linking with an on-strand generated o-quinone methide – a mechanistic rational for the exclusive 
formation of the interstrand product. 
The principle of guided modification has been further extended to nucleic acid tailoring by 
functionality transfer developed by the group of Sasaki.46 Their method for sequence-specific RNA 
modification relies on the use of a complementary DNA oligonucleotide probe, carrying an S-
alkylated 6-thioguanosine base at the desired position for modification (Scheme 20). The S-alkyl 
moiety has a character of a Michael acceptor and is transferred to the complementary cytosine 
nucleobase of the target strand upon hybridization. The initial attack of the exocyclic amino group of 
cytosine on the 1,4-conjugate system appears to be triggered by the close proximity between the S-
alkyl function and the target cytosine, brought by the DNA-RNA duplex formation. This strategy is 
unique in the sense that it not only delivers the modification sequence-specifically, but also allows for 
the release of the guiding strand without formation of cross-link products. 
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Scheme 20│ Functionality transfer strategy developed by Sasaki et al.46 
All post-synthetic approaches discussed so far except the direct alkylation with strong electrophiles 
insure the site-specific introduction of the desired functionality in a chemoselective manner and have 
proven valuable in a variety of specific tasks. They display, however, a few drawbacks that 
significantly narrow the scope of potential applications. For the methyltransferase approach that is 
mainly the variety of modified cofactors that the enzyme utilizes. One way to partially alleviate this 
problem is by re-designing the enzymes’s cofactor binding pocket. Studies with the model MTase 
M.HhaI have shown that a triple replacement of nonessential residues at the cofactor binding site leads 
to an increased catalytic efficiency of the alkyl transfer of some sterically demanding moieties.47 The 
chemical methods, on the other hand, although efficient and site-specific, are exclusively 
stoichiometric. A catalytic approach would be a viable alternative to the chemical and enzymatic 
methods described, as it combines increased group tolerance, thus greater substrate utility, with high 
reaction efficiency and chemoselectivity. Insertion reactions of metal-stabilized carbenoids are 
particularly well-suited for such purposes. They are efficient, require mild reaction conditions and 
have been applied for a broad variety of substrates. Two metals, rhodium(II) and copper(I), 
traditionally used in carbenoid chemistry, seem to be good candidates for such catalysts.  
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1.3.  Rhodium(II)-catalyzed X-H insertion reactions 
Dirhodium complexes are a unique class of compounds, containing a two-atom metal core (RhII-RhII) 
with up to four bridging bidentate ligands in the equatorial positions, and two additional axial 
coordination sites (Scheme 21).  
 
Scheme 21│ General structure of a dirhodium tetracarboxylate. 
Such dirhodium species display quite interesting coordination patterns and chemical reactivity. In 
particular, their reaction with -diazocarbonyl compounds gives rise to Rh(II)-stabilized carbenoids. 
These carbenoids are electrophilic and depending on the nucleophile present they can undergo a 
variety of transformations, such as insertions into polar bonds, cyclopropanations, and ylide formation 
to afford a great diversity of products (Scheme 22).48  
 
Scheme 22│ Rhodium(II)-catalyzed X-H insertion (a), cyclopropanation (b), and ylide formation (c). 
A class of reactions with a wide scope of practical applications are insertions into polar bonds of the 
type X-H, where X=C, Si, O, N, S. Scheme 23 shows several seminal examples for chemical 
transformations employing such X-H insertions reactions.  
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Scheme 23│ Examples of  X-H insertion reactions: a C-H carbenoid insertion closes up the D-ring on the steroid skeleton 2 
(A);49 a Si-H insertion for the preparation of the -silyl carbonyl adduct 4 (B);50 an O-H insertion with ethyl diazoacetate was 
used for the preparation of alkyl ethers 6 (C);51 an insertion into the N-H of the -lactam 7 as the key step of the thienamycin 
synthesis proposed by Merck (D),52 and a convenient route to unsymmetrically sulfenylated ketones 10 (E).53 
The implementation of metal carbene chemistry for biomolecular modification is of particular interest 
for the present study. Protein alkylation with rhodium(II)-stabilized carbenoids in aqueous medium as 
a bioconjugation strategy has been first suggested by Francis et al.54,55 They have demonstrated 
selective carbenoid insertion at N-1 and C-2 of the indole ring of exposed tryptophan residues 
(Scheme 24), accompanied by an excellent protein recovery and a moderate to good protein 
conversion.  
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Scheme 24│ Covalent modification of tryptophan residues in proteins with Rh(II)-carbenoids 
Later on Ball and Popp have utilized the same approach but with a peptide-ligated rhodium catalyst for 
modification, guided by coiled-coil peptide assembly.56,57 The specific binding of the catalyst-bearing 
peptide to the target delivers the metal carbenoid in the direct proximity of the modifiable 
functionality, resulting in a significant enhancement of its reactivity. This broadens the scope of 
accessible substrates, allowing for the efficient modification of a number of amino acid side-chains in 
addition to tryptophan (Scheme 25).       
 
Scheme 25│ Site-specific covalent modification of amino acid side-chains with Rh(II)-carbenoids: the metal carbenoid is 
delivered in close proximity to the modifiable group due to the coiled-coil interactions of the target and the catalyst chains.   
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On the other hand, it increases the selectivity for proximally located over randomly distributed 
potentially reactive groups, making selective targeting possible even in complicated mixtures, as 
demonstrated by the biotinylation of MBP-E3gW protein in total E.coli cell lysates.58   The generally 
accepted mechanism of carbenoid formation is analogous to that proposed by Yates for the copper-
catalyzed decomposition of -diazocarbonyl compounds (Scheme 26).59 It involves an initial 
coordination of the partially negatively charged -carbonyl carbon of the diazo substrate 12 to one of 
the axial positions of the dirhodium species, followed by loss of nitrogen from the intermediate 13 to 
afford the metal-stabilized carbenoid 14.  
 
Scheme 26 Generally accepted mechanism for the formation of rhodium-stabilized carbenes. 
The formation of the rhodium species 14 as the most likely reaction pathway has been suggested as 
early as in the work of Teyssie et al. on the cyclopropanation of alkenes with alkyldiazoacetates in the 
presence of rhodium carboxylates.60 Later on Pirrung and Morehead61,62 proposed a saturation kinetics 
treatment of the dirhodium catalysis with the coordination of the diazo substrate being fast and 
reversible (pre-equilibrium), and the loss of nitrogen being the rate-limiting step. The observed mixed 
type inhibition pattern with a number of axial binders (aromatic hydrocarbons and Lewis bases) 
suggests formation of only one carbenoid per molecule of catalyst, as the catalytic efficiency of the 
second axial site decreases upon coordination at the first one. In addition to that, Davies and 
Singleton63 show that in some cases the coordination of the -diazocarbonyl compound itself could 
proceed in an unproductive mode with the terminal nitrogen of the diazo group (15) or the carbonyl 
oxygen binding reversibly to the axial site of the rhodium catalyst (16) (Scheme 27). The electronics 
of the dirhodium core were further examined by Nakamura and co-workers64 who demonstrated the 
role of the back-donation upon initial coordination of the diazo compound for facilitating the nitrogen 
extrusion and the carbenoid formation, and the enhancement of the carbene reactivity by the electron-
withdrawing effect of the equatorial carboxylate ligands.  
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Scheme 27 -diazo carbonyl compound to the dirhodium catalyst 
Several theoretical studies62,63,64 have shown the free energy profile of the carbenoid formation step 
follows the general trend shown on Scheme 28. Coordination of diazo compound 12 to the dirhodium 
species results in a complex lower in energy (13) which then overcomes a relatively high activation 
energy barrier to expel nitrogen and afford the rhodium-stabilized carbenoid 14.    
 
Scheme 28│ General trend of the free energy profile of rhodium-catalyzed carbenoid formation 
Concerning the mechanism of the insertion step several different cases should be considered 
depending on the polarity of the X-H bond. Direct kinetic investigation of the insertion process has 
proven difficult since in almost all cases the loss of nitrogen is the rate limiting step.64 A widely 
accepted mechanism for the reaction of C-H insertion involves the formation of a concerted three-
center transition state (Scheme 29A) as proposed by Doyle et al.65 for a case of intramolecular 
cyclization in substituted -diazo esters. In a later study Nakamura et al.64 show the C-H insertion 
transition state is concerted but highly asynchronous with two events taking place as demonstrated by 
the corresponding resonance structures: a hydride transfer from the alkane to the carbene, and C-C 
bond formation and release of the ligated metal (Scheme 29B). A different mechanism has been 
proposed by the group of Taber.66 They hypothesize that the interaction between the electron-deficient 
carbene carbon and the target C-H in the form of a three-centered species is rapid and reversible, and 
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does not lead to the formation of the desired product. Instead, the reaction takes place through electron 
density redistribution in a different, four-centered transition state in which the target C-H is aligned 
with the Rh-C bond (Scheme 29C). A concerted C-H activation/C-C bond formation is consistent with 
retention of the configuration at the target C-H.67 A similar reaction pathway has been proposed for the 
reaction of Si-H insertion.68         
 
Scheme 29│ Concerted transition states for the rhodium-catalyzed C-H insertion: according to Doyle (A),65 Nakamura (B),64 
and Taber (C)66  
The mechanism of carbene insertion into polar bonds, such as N-H and O-H, is much less clear. There 
exist two main contradicting models: a concerted transition state very much alike the one observed 
with the C-H insertion, and a step-wise mechanism with formation of an ylide intermediate 17a or b, 
followed by a 1,2-proton shift (Scheme 30).69 Discussions arguing a concerted transition state being 
the more likely reaction pathway are quite inconclusive and solely based on indirect kinetic data70 or 
stereochemical reaction outcomes.71 A good rational for the latter mechanism are the experiments of 
Hu72 and Davies,73 in which an oxonium ylide, generated in situ from a rhodium carbenoid, is trapped 
with an imine, respectively subjected to a [2,3]-sigmatropic rearrangement. Another point, which 
should also be considered, is that the 1,2-proton shift could take place in the metal-bound (17a) or in 
the metal-free ylide (17b).     
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Scheme 30│ Step-wise mechanism of X-H insertion in polar bonds (X=N,O) involving the formation of an ylide (17a and b) 
  
1.4.  Copper(I)-catalyzed X-H insertion reactions 
X-H insertion reactions with copper(I)-stabilized carbenoids derived from -diazo carbonyl 
compounds have been known for decades, yet their synthetic significance and potential application 
have been overshadowed by other better developed catalytic systems. The works of Jørgensen,74 
Fu75,76 and Zhou77 have refocused the attention back to copper, demonstrating its catalytic efficacy in a 
number of stereoselective transformations of practical significance. 
The copper catalyst for such insertion reactions is usually formed in situ by mixing a catalyst precursor 
(e.g. Cu(OTf)2, CuBr , CuCl, Cu(MeCN)4PF6) with a strongly coordinating chiral ligand, such as  
bis(oxazoline) (19) and (20), semicorrin (21), or bis(azaferrocene) (22) (Scheme 31).74,75,76,77 
 
Scheme 31│ Examples of copper(I) ligands for asymmetric copper(I)-catalyzed N-H and O-H insertion reactions 
 
Concerning the oxidation state of the metal both Kochi78 and Teyssie60 have shown that in the 
presence of an -diazo carbonyl compound copper(II) is reduced to copper(I), which is the 
catalytically active species.   
Mechanistically the copper(I)-catalyzed polar X-H insertions (X=N, O) follow the general layout 
proposed for rhodium(II), involving coordination of the -diazo carbonyl compound to the metal 
catalyst, loss of nitrogen, and insertion of the electrophilic carbene formed into the X-H bond via the 
formation of an yilide intermediate and a subsequent 1,2-proton shift. In a computational study of the 
O-H insertion in water with a copper(I)/bis(oxazoline) catalyst Yu et al.79 suggest the insertion step 
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includes migration of the copper species from the -carbonyl carbon to the carbonyl oxygen with the 
formation of enolate 25b and a subsequent water-assisted proton transfer (26) with the metal catalyst 
tightly associated to the ylide intermediate (Scheme 32).  
 
Scheme 32│ Reaction mechanism for the copper(I)-catalyzed carbenoid O-H insertion in water as proposed by Yu et al. 79     
 
In a later study on N-H insertions with a well-defined binuclear chiral copper(I) catalyst Zhou et al.77 
demonstrate that the affinity of the metal catalyst towards the ylide can be tuned by changing the 
electronic characteristics of the substrates making both the metal-free (b→c) and the metal-associated 
pathways (d) possible (Scheme 33). They’ve also shown the 1,2-proton transfer is the rate-limiting 
step of the insertion reaction, which is consistent with the earlier observations of the group of Fu.75,76 
 
Scheme 33│ Possible reaction pathways for the copper(I)-catalyzed insertion of an aryl diazo alkyl ester into the N-H of an 
aniline as devised by Zhou et al.77 
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1.5.  Copper(I)-catalyzed azide-alkyne cycloaddition  
 
In addition to being suitable for carbenoid stabilization, copper(I) is the most widely used catalyst for 
2+3 azide-alkyne cycloaddition, or copper ‘click’ chemistry – a reaction of broad utility for chemical 
biology and biochemistry. The CuAAC, independently reported by Fokin and Sharpless,80 and by 
Meldal,81 (Scheme 34) is a star example for a ‘click’ reaction, as defined by Sharpless, a 
transformation easy to perform, resulting in high yields, with little or no by-products, carried out under 
mild conditions and unaffected by the nature of the functional groups on the entities being 
connected.82 In this process an azide and a terminal alkyne selectively form a 1,4-disubstituted 1,2,3-
triazole ring in a reaction of copper(I)-catalyzed cycloaddition.  
 
 
Scheme 34│Copper(I)-catalyzed azide-alkyne cycloaddition. 
 
The unique combination of several factors makes this transformation the coupling reaction of choice, 
especially when it comes to applications for bioconjugation.83,84 The two starting components alone 
are chemically relatively inert, and their reactivity remains almost unaffected by the steric and 
electronic properties of the groups attached.33 The reaction takes place in aprotic and protic solvents, 
and tolerates a large variety of functional groups. The 1,2,3-triazole ring formed is stable to 
hydrolysis, oxidation and reduction, has a large dipole moment (approximately equal to that of an 
amide bond), aromatic character and is able to participate in hydrogen bonding.84,85  
Copper in all three oxidation states (0, +I, +II) can be used as a metal source.85 Copper(I) salts (iodide, 
bromide, chloride, acetate) and complexes (e.g. [Cu(CH3CN)4]PF6, [Cu(CH3CN)4]OTf), as well as 
Cu(0), which is oxidized to the catalytically active Cu(I) by the molecular oxygen present in the 
reaction mixture, are all viable options. When using a copper(I) source oxygen-free conditions are 
required, as copper(I) gets oxidized to Cu(II) or disproportionates to Cu(0) and Cu(II). The use of 
Cu(II) salts is accompanied by sacrificial oxidation of the alkyne substrate to generate Cu(I) species, 
required for the catalysis. The combination of a copper(II) salt, such as copper(II)sulfate or 
copper(II)acetate and a mild reductant like ascorbate turns out to be a convenient strategy for the in 
situ generation of the copper(I) catalyst, particularly in aqueous systems used in bioconjugation 
reactions.80,86 The successful implementation of such a water-based copper(I) catalytic system is 
complemented by the use of appropriate ligands.  
A group of triazole-based ligands has gained popularity for such aqueous systems for CuAAC. Among 
them, tris(benzyltriazolylmethyl) amine (TBTA, 31),87 tris(tert-butyltriazolylmethyl)amine (TTTA, 
32) and  tris(3-hydroxypropyltriazolylmethyl)amine (THPTA, 33)86 (Scheme 35) are of particular 
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importance due to their ability to stabilize the copper(I) species, accelerate the cycloaddition reaction 
and scavenge the generated reactive oxygen species, which could otherwise cause oxidative damage to 
the target biomolecules.  
 
 
 
Scheme 35│Triazole-based ligands for CuAAC in water. 
 
A widely accepted mechanism for the CuAAC is the one depicted in Scheme 36.80 The formation of a 
copper acetylide is followed by coordination of the quite nucleophilic N-3 of the azide to the metal 
center. Back-donation from the metal enhances the nucleophilicity of the -acetylide carbon, which 
attacks the terminal electrophilic N-1of the azide, forming a six-membered cyclic intermediate, which 
then rearranges to a five-membered copper triazolide. Protonation of C-5 releases the triazole product 
and regenerates the metal catalyst. In a recent study the group of Fokin stipulates the involvement of 
not one, but two copper atoms in the catalytic process.88 They have shown that monomeric copper 
acetylides are unreactive towards azides, unless an exogenous copper catalyst is added. Crossover 
experiments with isotopically enriched exogenous copper species have led them to devise the 
mechanism shown on Scheme 37.  
 
 
Scheme 36│Mechanism of the CuAAC as initially suggested by Fokin and Sharpless. 
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One copper atom takes part exclusively in -complexation with the acetylene system, a second one 
acts purely as a -bond ligand, forming a copper acetylide. Reversible coordination of the azide is 
followed by a nucleophilic attack by the -acetylide carbon. At this stage the ligand exchange on the 
two copper centers takes place faster than the next C-N bond forming event, allowing isotopic 
enrichment of the bimetal species. Once the C-N bond is formed, one metal atom leaves the system, 
yielding a five-membered copper triazolide, which after protonation of C-5 releases the triazole 
product and the second copper atom. 
 
 
 
Scheme 37│Proposed catalytic model for CuAAC with two copper atoms. 
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Chapter 2. Nucleic acid alkylation with Rh(II) carbenoids 
The aim of the work discussed in this chapter was to establish a direct catalytic approach for post-
synthetic DNA and RNA alkylation using rhodium(II)-stabilized carbenoids. 
 
 
2.1. Alkylation of single-stranded DNAs and RNAs 
 
The rhodium(II)-catalyzed conversion of -diazo carbonyl compounds has been established as a 
powerful approach for generating rhodium carbenoids. These compounds could then undergo a 
number of useful transformations such as insertions into polar bonds. Rhodium(II) carboxylates are 
also known for their ability to bind DNA and RNA molecules.89 The extensive structural 
characterization of the Rh(II)-DNA complexes has shown that such binding can occur in different 
ways depending on the oligonucleotide structure. This can lead to striking changes in DNA 
conformation that, in turn, can alter its physiological activity in the living cell.90,91,92 On the other hand 
DNA and RNA possess a number of nucleophilic groups which can be involved in reactions with the 
rhodium(II)-stabilized carbenes. However, in the literature so far there is no precedence for addressing 
such a possibility. In addition, the interactions between the catalytic dirhodium species and the 
oligonucleotides could be exploited for the proper targeting and modulation of the activity of the 
catalyst. 
The -diazo carbonyl substrate plays a decisive role in establishing an efficient metal-carbene system 
for nucleic acid alkylation. The diazo substrate 11, commonly utilized for the amino acid side-chain 
modification in aqueous media,54,55,56,57 is sparingly soluble in water and requires the use of a co-
solvent. In addition, even when stored neat at -20°C, it tends to form a cyclic side-product (34) most 
likely through a reaction of an intramolecular dipolar cycloaddition. To avoid these problems a re-
design of the diazo substrate was done.  
 
 
 
In the new -diazo substrate Dz1 (37) the -carbon was directly connected to the phenyl ring, 
omitting the 3,4-double bond fragment, the PEG ester group was replaced with a methyl group, and a 
N,N-dimethylaminomethyl residue was installed in para-position of the phenyl ring to improve the 
water solubility. Dz1 was accessed in only three synthetic steps: methylation of commercially 
available (4-bromomethyl)phenylacetic acid (35) under mild conditions, followed by a substitution of 
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the benzylic bromide and a nucleophilic diazo transfer afforded the target molecule in a moderate 
yield (Scheme 38). Dz1 was well-soluble in aqueous buffers at pH  6 (concentrations of up to 
250mM) and was stable for several days at that pH at room temperature. 
 
 
 
Scheme 38│Synthetic sequence for preparation of Dz1 (37). 
 
In a proof-of-concept experiment a short single-stranded oligonucleotide d(ATGC), containing the 
four canonical DNA bases, was subjected to alkylation with Dz1 in the presence of 10 mol% 
Rh2(OAc)4 in a buffered aqueous medium at room temperature (Scheme 39).  
 
 
Scheme 39│Proof-of-concept experiment for rhodium-carbenoid alkylation. 
 
HPLC/MS analysis of the reaction mixture after 24 h revealed that more than half of the starting 
oligonucleotide (56 %) had been converted to a number of singly and doubly modified oligonucleotide 
species (Figure 1). MS/MS analysis revealed that the modification had taken place exclusively on the 
purine nucleobases (Figure 2 and 3). A direct evidence for that were the molecular ion fragments after 
loss of the alkylated base (M-B)+, which were found in all cases. In addition to that the samples 
displayed the typical for DNA a/w-fragmentation patterns, with the expected a- and w-ions present.   
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Figure 1│Alkylation of d(ATGC) with rhodium carbenoids: HPLC trace of the reaction mixture after 24 h. The numbers 
indicate the molecular weight of the oligonucleotide in the respective fraction. The number of alkylations per molecule of 
oligonucleotide and the modified base(*) as determined by MS/MS are given in parenthesis.    
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Figure 2│Alkylation of d(ATGC) with rhodium carbenoids: ESI-MS (A) and MS/MS (B, C) characterization of fractions, 
containing monoalkylated products. The fragmentation patterns are consistent with a modification on guanine (B) and 
adenine (C). 
 
33 
 
 
 
 
 
   
Figure 3│Alkylation of d(ATGC) with rhodium carbenoids: ESI-MS (A) and MS/MS (B) characterization of a fraction, 
containing dialkylated products.   
 
Experiments with the four homotetramers d(A)4, d(C)4, d(T)4, and r(U)4 (Table 1, entries 1-4) were 
particularly important for assessing of the individual propensity of each base towards alkylation. The 
oligonucleotides d(C)4 and d(A)4 demonstrated good reactivity and were converted to a number of 
singly- and doubly-modified species at moderate conversions of the starting oligonucleotides. In 
contrast, the thymine and the uracil tetramers proved to be completely unreactive. This on one hand 
suggests that the alkylation does not take place on the ribo-phosphate backbone of the oligonucleotide, 
and on the other, that the functionality responsible for the cytosine and adenine reactivity is not 
present in the thymine and uracil nucleobases. It should be noted that the cytosine tetramer was 
efficiently alkylated in contrast to the data from the d(ATGC) experiment. This was accompanied by a 
complete conversion of the Dz1 in less than 3 h, which was not the case for d(A)4, d(T)4, and r(U)4, 
where only partial consumption of the diazo substrate was observed even after 24 h incubation, 
indicating decreased overall activity of the catalyst in the latter cases. 
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Table 1│Scope of the rhodium(II)-carbenoid alkylation with single-stranded DNA and RNA oligonucleotides. 
Entry Substrate 
Number of alkylation products Conversion of 
oligonu-
cleotide, %a 
Conversion of 
Dz1, %a 
N-H/O-H 
selectivity 
factorb Monoalkylation Dialkylation 
1 d(T)4 0 0 0 20 0 
2 r(U)4 0 0 0 30 0 
3 d(A)4 4 2 39 40 - 
4c d(C)4 6 6 45 >98 - 
5d d(TAT) 2 0 20 >98 282 
6d,e d(TGT) 2 0 25 >98 282 
7c,d d(TCT) 2 0 16 >98 210 
8d d(ATGC) 4 2 56 >98 - 
9 r(ACU GCU) 3 0 68 >98 9970 
10 d(ACT GCT) 5 1 56 >98 - 
11 d(CTC TCT) 2 0 32 >98 1550 
12 d(CTG GCT) 6 0 42 >98 1050 
13 
d(TTT ATT TGT 
TTC TTT) 
4 2 37 >98 - 
 
Reaction conditions: 5 mM oligonucleotide, 50 mM Dz1, 0.5 mM Rh2(OAc)4, 50 mM MES buffer, pH 6.0, 24 h at room 
temperature. a Conversion of the starting material, oligonucleotide or Dz1, determined by HPLC. b Determined by 
multiplying the ratio N-H/O-H insertion products by the effective concentration of N-H and O-H nucleophiles; calculated for 
cases with only monoalkylation products. c Dz1 was completely consumed after 3 h. d Alkylation sites determined by 
MS/MS analysis. e 5 mM d(TAT), 5 mM d(TGT), 1 mM Rh2(OAc)4.  
 
The tetramer d(G)4 displayed quite an interesting behavior, as attempts to alkylated it alone were 
unsuccessful. In a mixed experiment, however, in the presence of the other three DNA tetramers, it 
was efficiently modified (Figure 4). d(T)4 proved again to be unreactive, as no traces of modified 
products were found.  
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Figure 4│HPLC trace of the modification reaction of a mixture of d(A)4, d(C)4, d(G)4, and  d(T)4 with rhodium carbenoids. 
Peak identification was done by ESI-MS.  
 
The modification experiments were continued on three nested oligonucleotide trimers d(TCT), 
d(TAT), and d(TGT) in order to examine the individual reactivity of each nucleobase, assuming that 
no reaction took place on thymine or the ribo-phosphate backbone of the oligonucleotide. Once again 
alkylation of d(TGT) was only possible upon addition of a second oligonucleotide, in this case 
d(TAT). In all three cases two monoalkylation products were formed as indicated by the HPLC/MS 
analysis of the reaction mixtures (Figure 5 and 6). The trimer d(TGT) showed the highest propensity 
for alkylation and d(TCT) the fastest consumption of Dz1. Tandem MS analysis of the modified 
products showed an intense signal for the modified B2, accompanied by the respective a2-ion - a clear 
evidence that the modification had taken place on the adenine, cytosine or guanine without affecting 
the thymine bases, the 2′-deoxyribose or the phosphate groups (Figure 7).  
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Figure 5│HPLC trace of the modification reaction of d(TAT) (A) and d(TCT) with Dz1. The product masses and the number 
of alkylations per oligonucleotide molecule (in parenthesis) are indicated for each peak.   
 
 
Figure 6│HPLC trace of the modification reaction of a mixture of d(TGT) and d(TAT) with Dz1. Only monoalkylation 
products were detected. The asterisk after the base shows the position of modification established by MS/MS. 
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Figure 7│MS/MS fragmentation of singly-modified d(TAT) (A), d(TCT) (B), and d(TGT) (C) with Dz1. 
 
The oligonucleotide substrate study was complemented by a few medium-sized DNA and RNA 
oligonucleotides, tested under the alkylation conditions described above (Table 1). In all cases (entries 
9-13) moderate to good conversions were observed, as the presence of guanine in the structure 
generally increased the yield of modified oligonucleotide. Concerning the type of nucleic acid entries 
9 and 10 demonstrate, that RNAs can not only be targeted, but in fact more efficiently alkylated than 
comparable DNAs.  
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If not used for nucleic acid alkylation, the diazo substrate was directed to O-H insertion in water, 
giving the secondary alcohol product. Assuming that the alkylation takes place on a nitrogen 
nucleophile on the base (N-H insertion) an N-H/O-H insertion selectivity factor was calculated for the 
examples which only give rise to monoalkylation products (Table 1). It shows a remarkable preference 
for N-H over O-H insertion despite of the overwhelming excess of water in the reaction system.  
 
 
2.2 Regioselectivity of the alkylation. Determination of the alkylation sites: tandem MS and 
NMR experiments 
 
The reactivity of the homotetramers together with the information from the tandem MS experiments 
with d(ATGC) and the three nested trimers delivered a direct evidence for the involvement of the 
adenine, guanine and cytosine nucleobases in the alkylation process. Each nucleobase itself contains a 
number of reactive nucleophilic centers, which could take part in an insertion reaction with the 
rhodium carbenoid (Scheme 40).  
 
 
Scheme 40│Potential reactive sites for insertion of the rhodium carbenoid. 
 
A more rigorous structure characterization of the reaction products was needed in order to precisely 
define the alkylation site on the nucleobase and establish the regioselectivity of the modification 
reaction. Such structure elucidation was completed by NMR spectroscopy. In principle, the 
unambiguous assignment of NMR structures could be quite challenging even of short oligonucleotides 
due to the large number of similar proton and carbon resonances. In order to alleviate that problem a 
13C-labeled analogue of Dz1 (40) was prepared. The 13C-label was introduced in -position to the 
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carbonyl carbon, which after carbenoid formation/insertion would directly contact the target 
oligonucleotide structure. The preparation of compound 40 was carried out as outlined in Scheme 41 
starting from commercially available 4-(bromomethyl)bromobenzene (38). It was subjected to 
benzylic substitution with dimethylamine to give the respective 4-
(dimethylaminomethyl)bromobenzene (39). Palladium-catalyzed C-C bond formation of that product 
with ethyl acetoacetate-2,4-13C2, followed by an in situ elimination of acetate yielded intermediate 
39a. A subsequent transesterification for exchanging the alkyl ester group from ethyl to methyl (39b) 
and a nucleophilic diazo transfer on the -carbon afforded the desired compound 40 in 27 % isolated 
yield over four steps.  
 
 
 
Scheme 41│Synthetic sequence for preparation of the -13C-labeled analogue of Dz1 40. (a) Me2NH in EtOH (70 %). (b) i. 
Ethyl acetoacetate-2,4-13C2, Pd(OAc)2, 2-(di-tert-butylphosphino)-2′-methylbiphenyl, K3PO4.H2O in toluene, ; ii. NaOMe in 
MeOH; iii. pABSA, DBU, MeCN (38 %).  
 
The modification experiments were carried out on the three nested oligonucleotide trimers d(TCT), 
d(TAT), and d(TGT), already used in the oligonucleotide substrate scope study. Preparative separation 
of the two product species found for each oligonucleotide in the analytical assay was not possible, so 
in all cases they were further analyzed as mixtures.  
31P NMR spectra of the total modified fractions showed two sets of phosphate signals. The resonance 
shifts and the peak ratios suggest they most likely correspond to the two diastereomers of the same 
singly-modified product (Figure 8 and 9).  
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Figure 8│31P NMR spectra of non-modified (A) and modified d(TCT) (B) with compound 40.  
 
 
 
Figure 9│31P NMR spectra of d(TAT) (A) and d(TGT)(B), modified with compound 40.  
 
The NMR investigation of each product mixture included 1D experiments in H2O and D2O, and 2D 
experiments in D2O for a complete structure assignment. A conclusive result for the position of the 
alkylation was first obtained for the modified d(TCT). 1H NMR analysis in H2O of the alkylated 
d(TCT) revealed the following resonance pattern for its H-8: (a) two sets of signals, one for each 
diastereomer; (b) a large coupling to the adjacent -13C (1JH8-C8 = 145.7 Hz); (c) a smaller coupling 
(3JH8-HN = 5.4 Hz) to the NH of the exocyclic nitrogen of the cytosine base (N-4) (Figure 10A). When 
the 1H NMR was measured in D2O, the latter coupling collapsed due to the H/D exchange of the NH 
(3JH8-DN < 0.8 Hz). This was an unambiguous proof for the attachment of the C-8 to the exocyclic 
amino group of the cytosine (Figure 10B). 
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Figure 10│1H NMR resonances of H-8 of modified d(TCT) in H2O (A) and D2O (B).  
 
Further evidence substantiating the tag positioned on N-4 came from the ROESY spectra of the 
modified products. The ROE contacts between the H-5 of the cytosine base and the ortho-protons (H-
13 and H-13a) of the aromatic portion of the tag were clearly observable (Scheme 42). In addition, no 
3J correlations of the H-8 to C-2 or C-4 of the cytosine were found. Such interactions would be rather 
intense in case the tag was positioned at N-3. 
  
 
 
Scheme 42│ROE contacts of the singly-modified d(TCT) with compound 40.  
 
These results were in agreement with the data from the MS3 analysis of the modified d(TCT). 
Fragmentation of the ion of the modified base showed product ions, consistent with alkylation of the 
cytosine N-4 (Figure 11).  
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Figure 11│MS3 fragmentation of the modified cytosine base, obtained in MS/MS fragmentation of the alkylated d(TCT).  
 
The 1H NMR data for the modified d(TAT) was rather inconclusive due to the significant broadening 
of the H-8 resonance both in H2O and D2O. The results for the modified d(TGT) on the other hand 
confirmed alkylation on the exocyclic amino group of guanine. The observed 3JH8-HN coupling in H2O 
was smaller than that for d(TCT) and resulted in a peak broadening rather than in a clear multiplicity 
pattern (Figure 12). The peak width, however, decreased almost by half when the sample was 
measured in D2O due to the H/D exchange on the NH-group and collapse of H8-HN interactions. 
Establishing the alkylation site for guanine is particularly important for the present study, as it 
excludes the involvement of the O-6, which is also a potential target and narrows down the reaction 
scope to nitrogen nucleophiles only.  
 
 
 
Figure 12│1H NMR resonances of H-8 of modified d(TGT) in H2O (A) and D2O (B).  
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2.3. Scope of -diazocarbonyl substrates and conditions for nucleic acid alkylation 
 
The effect of the diazo substrate structure on the modification process was examined with the -
diazocarbonyl compounds shown in Table 2.  
 
Table 2│Scope of diazo substrates and reaction conditions for the rhodium(II)-carbenoid alkylation with single-stranded 
DNA. 
Entry Diazo substrate 
Dz, 
mM 
Buffer 
Oligonucleotide 
conversion, %[a] 
1 Dz1 
 
50 100 mM MES, pH 6.0 56 
2 Dz1 50 75 mM tBuNHOH, pH 6.0 52 
3 Dz1 50 100 mM KPi, pH 6.0 52 
      
4 Dz2 
 
50 100 mM MES, pH 6.0 24 
      
5 Dz3 
 
50 100 mM MES, pH 6.0 48 
6 Dz3 50 100 mM KPi, pH 6.5 51 
7 Dz3 50 100 mM KPi, pH 7.5 50 
      
8[b Dz4 
 
25 100 mM MES, pH 6.0 30 
      
9[c Dz5 
 
50 100 mM MES, pH 6.0 51 
      
 
Reaction conditions: 5 mM d(ATGC), 0.5 mM Rh2(OAc)4. [a Oligonucleotide conversions were estimated from the HPLC 
traces of the reaction mixtures after 24 h at room temperature. [b 50 % (v/v) ethylene glycol as a co-solvent. [c d(TTT ATT 
TGT TTC TT) used as substrate instead of d(ATGC).    
 
The alkylation reaction appears to be quite tolerant towards the diazo substrate structure, as a number 
of diverse functionalities were accepted, as long as the steric hindrance of the alkyl ester group was 
kept to a minimum. The negative effect of the increased size of the ester group was clearly 
demonstrated by Dz2 (41) in entry 4, whose reactivity towards the nucleic acid was reduced by half in 
comparison to Dz1 upon only a single carbon extension of the alkyl chain. On the other hand, the 
diazo substrates in entries 5 to 10 all showed moderate to good oligonucleotide conversions, which 
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were not dependent on the complexity of the aryl structure. Such reaction versatility would be 
particularly useful in some labeling applications, where the presence of certain chemical tags on the 
diazo substrate would allow further chemoselective modification of the alkylated nucleic acids. Two 
such examples are Dz4 (44) and Dz5 (45) (entries 8 and 9), bearing alkyne tags for decoration with 
azide-tagged markers by CuAAC.  
Another important characteristic of the -diazocarbonyl compound is its water solubility. The standard 
alkylation protocol was optimized for a 10-fold excess of diazo substrate with effective concentrations 
of 50 mM. Tertiary or quaternary amines tend to improve the compound solubility in water, hence 
their use as ‘solubilizing’ motifs throughout the entire substrate series (Table 2). The addition of co-
solvents in order to increase the solubility was typically avoided, as in most cases they were either 
incompatible with the nucleic acid causing it to precipitate (e.g. alcohols) or coordinated strongly to 
the dirhodium catalyst diminishing its activity (DMSO). In the case of Dz4 ethylene glycol was used 
as a co-solvent in a 1:1 mixture with the aqueous phase (entry 8). It should be noted, however, that in a 
separate experiment the addition of the same amount of ethylene glycol decreased the yield of 
alkylated d(A)4 by half (from 39 to 20 % conversion of the oligonucleotide). In that sense the 
solubility of the alkyne-tagged diazo substrate Dz4 was improved by altering the compound’s 
structure. The introduction of a second piperazine ring and a short PEG-chain afforded a compound 
fully soluble at a concentration of 50 mM allowing for satisfying yields of alkylation (Entry 9).  
The alkylation reaction was typically carried out at pH 6.0, as this pH insures the stability of the 
nucleic acid species and in the same time is optimal for the diazo substrate solubility. Experiments 
with the N-permethylated Dz3 (42) showed that the alkylation efficiency remained practically the 
same in the pH range up to 7.5 (Table 2, entries 5-7). The nature of the buffering substance appeared 
to have very little effect on the reaction at pH 6.0 (Table 2, entries 1-3). The addition of N-tert-
butylhydroxylamine, which was previously discussed as beneficial in the case of protein alkylation,55 
seemed to have no effect on the reaction with nucleic acids (Table 2, entry 2).      
 
2.4. Mechanistic rational for the Rh(II)-carbenoid nucleic acid modification   
 
A mechanistic assessment of the rhodium(II) alkylation system could prove difficult due to the 
complexity of the reaction substrates, the possibility for multiple coordination states of the rhodium(II) 
catalyst and the presence of a side-reaction of O-H insertion, taking place concurrently and accounting 
for over 90 % of the diazo substrate conversion. 
Such mechanistic assessment was attempted for the alkylation of the three nested DNA trimers 
d(TCT), d(TAT) and d(TGT) with Dz1. It should be noted that both the oligonucleotides and the diazo 
substrate contain a number of Lewis basic groups, which could potentially coordinate to the metal 
center altering its catalytic properties. Attempts to carry out an O-H insertion reaction with Dz1 and 1 
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mol% rhodium(II) tetraacetate in aqueous buffer in the absence of an oligonucleotide delivered less 
than 35 % overall conversion of the diazo substrate over 20 h at room temperature, while in the 
presence of d(TCT) or d(TAT) complete conversion of Dz1 to the respective N-H and O-H insertion 
products was observed. The protective role of the oligonucleotide substrate clearly indicate the 
presence of ligand effects, which are responsible for the drastic changes in the rhodium(II) catalytic 
activity.  
The coordination of nucleoside derivatives, as well as oligonucleotides and DNA and RNA to 
rhodium(II) is also a well-known phenomenon. The coordination of adenine and adenosine in 
particular, first described by Farrell for rhodium(II) tetraacetate,93 takes place at the axial position of 
the bimetal core through N-7 of the nucleobase (Scheme 43A).  
 
 
 
Scheme 43│Axial coordination of an adenine (A) or a guanine derivative (B) to Rh2(OAc)4.    
 
The interaction is additionally stabilized by hydrogen bonding between the exocyclic amino group of 
the adenine (N-6) and the carboxylate oxygen of the acetate ligand. A similar interaction is to be 
expected for the cytosine base, although the literature data about its axial coordination in rhodium(II) 
tetracarboxylates is absent. 
The complex formation between d(TCT) and d(TAT) and the dirhodium species was confirmed by 
kinetic studies. Experiments with d(TCT) and d(TAT), rhodium(II) tetraacetate and Dz1 showed 
significantly different rates of diazo substrate disappearance, as 1/2 for d(TCT) was around eight times 
smaller than that for d(TAT) (Figure 11). 
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Figure 11│Time curves for the overall conversion of Dz1 in the presence of Rh2(OAc)4 and d(TCT) or d(TAT).  
 
Having in mind that the oligonucleotide N-H insertion reaction accounts for less than 3 % of the total 
Dz1 conversion, the nature of the nucleobase should not significantly affect the rate of the O-H 
insertion process, unless the oligonucleotide itself would be able to bind to the catalyst and alter its 
activity. A possible mechanistic model involving oligonucleotide pre-coordination to the rhodium 
tetraacetate catalyst is depicted in Scheme 44 for the case of d(TAT). The process sequence that would 
take place also in the absence of a coordinating nucleobase would start with coordination of the diazo 
substrate to the rhodium catalyst, yielding complex 49, followed by loss of nitrogen to give carbene 
50, which then reacts with an amine or water to afford the final insertion products 51 and 52 
respectively. An additional axial coordination of the adenine nucleobase could in principle take place 
at any stage of the process, hence intermediates 48, 49′ and 50 should be considered. According to the 
findings of Pirrung and Morehead if one axial site on the dirhodium core is already occupied the 
second axial site should have a significantly decreased binding capability, thus diminished catalytic 
acitivy.61,62 In that sense the formation of species 49′ from 48 should be rather unfavorable but still 
possible if the coordination of the -carbon of the diazo substrate were accompanied by a partial 
ligand dissociation at the distal axial site, as well as in the equatorial positions. On the other hand the 
increased electron density of the bimetal core in 49′ should favor the back-donation from the 
dirhodium to the coordinated diazo compound, thus facilitating the extrusion of nitrogen and the 
formation of carbenoid 50′. Finally, nucleobase coordination or dissociation after the carbene has 
formed should be considered only if these were significantly faster than the N-H and O-H insertion 
reactions consuming that very carbene.            
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Scheme 44│Putative mechanistic model of Dz1 conversion in the presence of Rh2(OAc)4 and d(TAT).   
 
The alkylation of d(TGT) presented quite an interesting case. Attempts to alkylate d(TGT) alone were 
unsuccessful. Addition of an equimolar amount of d(TAT) to the reaction mixture alleviated that 
problem, yielding efficient alkylation of both trimers. This is another evidence of the protective role of 
the adenine axial coordination. The inability of guanine to form stable complexes to the axial position 
of rhodium(II) could be explained with repulsive interaction, occurring between the O-6 of guanine 
and the oxygen of the carboxylate equatorial ligand (Scheme 43B). 
The individual reactivity of the nulceobases in the N-H insertion step was determined in a competition 
experiment with the three trimers d(TCT), d(TAT), and d(TGT) (Figure 12). The propensity for 
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alkylation decreased in the order: G>A>C with oligonucleotide conversion 25, 18, and 12 % 
respectively. It should be noted, that nucleobase targeting appears to be sequence-specific, as for 
example the fully reactive base cytosine remained completely untouched in the d(ATGC) 
oligonucleotide. 
 
 
 
Figure 12│HPLC trace of the mixed alkylation of d(TCT), d(TAT), and d(TGT) with Dz1 in the presence of Rh2(OAc)4. The 
total peak area of modified d(TCT) is determined from the peak area of the resolved diastereomer assuming equal amount for 
the other diastereomer.    
 
 
2.5. Structure selectivity of the Rh(II)-catalyzed alkylation: experiments with double-stranded 
DNAs and RNAs 
 
Double-stranded DNAs and RNAs are an inseparable part of the nucleic acid structure variety. In fact 
only the actively replicated and transcribed DNA could be found in the single-stranded form. The 
situation with RNA is even more complex, as all types tend to form diverse secondary structures with 
alternating single- and double-stranded regions. In that sense the ability of the rhodium(II) alkylation 
system to target nucleic acid duplex motifs is an important characteristic concerning the method scope 
and potential practical application.  
The double-strand alkylation experiments were performed on model DNA and RNA hair-pins (Table 
3). The use of hair-pins has several advantages over nucleic acid duplexes pre-formed by mixing 
equimolar amounts of the respective complementary strands. It requires the synthesis and purification 
of only a single strand and, when properly designed, it insures the quantitative formation of the desired 
duplex species only. Several conceptually different structures were generated by only small changes in 
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the base sequences. All of the hair-pins used contained a small loop of five nucleobases and a short 
duplex portion (6-10 bp).  
 
Table 3│Scope of the rhodium(II)-carbenoid alkylation with double-stranded DNA and RNA oligonucleotides. 
Entry Hair-pin substrate Structure 
Conversion, 
%[a] 
1 HP1 d(CGAACGTTTTTCGTTCG) 
 
 0 
2 HP2 d(CGAACGTTTTTCGTTCGA) 
 
21 
3[b] HP3 d(ACGGAATTCCGTTTTTCGGAATTCCG) 
 
19 
4 HP4 d(CGAACGTTATTCGTTCG) 
 
  
 6    
  22[c] 
5 HP5 r(CUAGCAUUUUUUCGUAGA) 
 
 
19    
   33[c] 
 
Reaction conditions: 5 mM oligonucleotide, 50 mM Dz1, 0.5 mM Rh2(OAc)4, 100 mM MES buffer, pH 6, 24 h at room 
temperature. [a] Oligonucleotide conversion determined form the HPLC analysis of the reaction mixtures. [b] This sequence 
contains a restriction site for EcoRI. Alkylation at 5′-adenine overhang confirmed by MS/MS analysis of the restriction digest 
with EcoRI. [c] Conversion after addition of a second portion of Dz1 and 24-h incubation. 
  
Alkylation of the hair-pins was attempted with Dz1 under the conditions already worked out for the 
single-stranded nucleic acids. Hair-pin structure 1 (HP1, Table 3, Entry 1), containing only unreactive 
thymine bases in the loop and no overhangs in the stem region was completely inert to alkylation with 
rhodium carbenoids, showing that bases, engaged in double strands, were not targeted. Once a reactive 
base (adenine) was introduced outside the duplex region as a 3′- (HP2, Entry 2) or a 5′-overhang (HP3, 
Entry 3), or as a base in the loop region (HP4, Entry 4) modest conversions of the oligonucleotide to 
the monoalkylated products were observed. The reactivity of HP4 with adenine in the loop region was 
significantly lower than that for HP2 and HP3, and required the addition of a second portion of Dz1 
and longer incubation times (48 h) to achieve the same oligonucleotide conversion. This was most 
likely due unfavorable sterics of the adenine in the loop structure. The propensity for alkylation of the 
RNA hair-pin HP5 with a 3′-adenine overhang was comparable to that of the DNA counterparts (Entry 
5). 
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The position of the alkylation, occurring outside of the duplex region, was confirmed with HP3, which 
contained a restriction site for the restrictase EcoRI inside the stem. Upon treatment with Dz1 in the 
presence of Rh(II) the formation of two sets of alkylation products M1 and M2 was observed  (Figure 
13). The alkylation products were isolated by micro-preparative RP-HPLC and digested with EcoRI to 
release fragments F-I to III shown on Scheme 45. HPLC-MS confirmed the presence of the singly-
modified fragment F-I and the unmodified fragment F-II in the restriction digest. Further MS/MS 
analysis of the monoalkylated F-I revealed the modification had taken place on the adenine base of the 
5′-overhang (Figure 14). 
The ability of the rhodium carbenoids to efficiently select for single- over double-stranded nucleic acid 
motifs is an important feature of the method and could be of direct practical significance. Such 
structure selection could be utilized for site-specific alkylation of single strands using duplex 
formation as a protection strategy. The target sequence is mixed with one or several shorter 
complementary chains, which after duplex formation would leave only the desired bases exposed, 
allowing site-specific delivery of the desired modification. Subsequent purification under denaturing 
conditions should yield the target species with the desired modification in place. 
 
 
 
Figure 13│HPLC trace of the Rh(II)-catalyzed alkylation of HP3 with Dz1. The product masses and the number of 
alkylations per oligonucleotide molecule (in parenthesis) are indicated for each peak.   
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Scheme 45│Restriction fragments of HP3 upon treatment with EcoRI. The alkylated 5′-end adenine is indicated with an 
asterisk.  
 
 
Figure 14│Tandem MS fragmentation of the 5′-end fragment d(A*CGG) from the EcoRI restriction of the modified HP3. 
The alkylated 5′-end adenine is indicated with an asterisk. 
 
 
2.6. Nucleic acid labeling applications 
 
The direct introduction of label moieties already in the diazo substrate structure proved to be tedious 
and resulted in sterically crowded compounds which were poorly soluble in water, displaying less than 
optimal alkylation properties as in the example of Dz7. In a more facile divergent strategy only a 
single chemical tag (alkyne group) was installed on the diazo substrate used for nucleic acid 
alkylation. Diversification of the product structure was done on a later stage by chemoselective 
functionalization of the alkyne tag by CuAAC with appropriately labeled azides.  
All labeling experiments were carried out with Dz5 discussed earlier, which was prepared as outlined 
in Scheme 46. The dipiperazine tri(ethyleneglycol) spacer arm was constructed starting from 1-
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bromotetra(ethyleneglycol) (45a), then installed on the diazo core structure by benzylic substitution in 
compound 36. Boc-group removal under neutral conditions, followed by N-propargylation of the 
terminal piperazine afforded compound 45f, which after nucleophilic diazo transfer on the -carbonyl 
carbon yielded Dz5 (45).   
 
 
 
Scheme 46│Synthetic sequence for preparation of Dz5 (45): (a) Boc-piperazine, K2CO3. (b) pTsCl, Et3N, DMAP. (c) LiBr. 
(d) Piperazine, K2CO3. (e) i. 36, K2CO3; ii. TMSOTf, 2,6-lutidine; iii. Propargyl bromide, K2CO3. (f) pABSA, DBU.   
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Figure 15│HPLC-separation of the modification reaction mixture of d(TTT ATT TGT TTC TTT) with propargylated Dz5. 
The isolated fraction of main monoalkylation product is indicated by the solid peak area. The product masses determined by 
MALDI-TOF and the number of alkylations per oligonucleotide molecule (in parenthesis) are indicated for each peak. 
 
Modification with Dz5 was first done with the model DNA 15-mer d(TTT ATT TGT TTC TTT). A 
number of singly-, doubly- and even triply-modified products were formed at a 51 % conversion of the 
oligonucleotide as judged by the HPLC-analysis of the reaction mixtures (Figure 15). The main 
monoalkylated product was isolated preparatively and further modified with rhodamine B and biotin-
tagged azides 46 and 47 respectively under the conditions described by Finn et al.86 to afford the 
respective ‘click’-products (Figure 16). 
 
 
 
The utility of the nucleic acid alkylation with rhodium(II) carbenoids was then demonstrated by the 
fluorescent tagging of T7 promoter primer for preparation of labeled PCR amplicons (Scheme 47). T7 
promoter primer with a 5′-d(C)4-extention (d(C)4-T7PP) was first alkylated with Dz5 in the presence 
of Rh2(OAc)4, and then coupled to rhodamine B azide via CuAAC. The identity of the products was 
confirmed by MALDI-TOF and their viability as functioning primers – in a PCR assay with a 275-bp 
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test template sequence, followed by an agarose gel electrophoretic analysis of the PCR mixtures. 
Successful labeling was first indicated by the presence of a fluorescent PCR amplicon already before 
DNA visualization with ethidium bromide (Lane 5a). 
 
Figure 16│HPLC-separation of the ‘click’ reaction of the main monopropargylated d(TTT ATT TGT TTC TTT) with 
rhodamine B (A) and biotin azide (B).  
 
The ethidium bromide soak showed amplification comparable to that with the control primer (Scheme 
47, Lane 2b and 5b). The propargylated d(C)4-T7PP, both purified (Lane 3b) or directly from the 
alkylation reaction mixture (Lane 4b) also delivered the desired amplification product. Despite the 
random manner of base modification, the described approach was able to produce fluorescently 
labeled PCR product of the correct length and in satisfying yields. It is likely that only modifications 
close to the primer 5′-end would result in efficient template binding and amplification of the desired 
sequence. Since the PCR primers are normally added in a large excess, even the small fraction of 
‘properly’ modified at the 5′-end primer molecules should be sufficient for a robust amplification of 
the target sequence. The ease of label incorporation and the possibility to tag virtually any practically 
important primer sequence makes the method a viable alternative to the standard pre-synthetic nucleic 
acid modification approaches. 
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Scheme 47│Preparation of fluorescently labeled PCR amplicons using the rhodium(II) alkylation strategy. 5′-d(C)4-extended 
T7 promoter primer was alkylated with Dz5 and a rhodamin B tag installed by CuAAC. Electrophoretic analysis of a PCR 
amplification of a 275-bp sequence. Lane 1: 100 bp DNA ladder, lane 2: PCR with d(C)4-T7 promoter primer, lane 3 and 4: 
reactions with purified and crude propargylated d(C)4-T7 promoter primer (T7PP*), lane 5: PCR with the fluorescently 
labeled d(C)4-T7 promoter primer (T7PP**); (a) before, (b) after incubation with ethidium bromide.   
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2.7. Conclusions and future directions 
 
A novel alkylation method for short and medium-sized DNA and RNA oligonucleotides using 
rhodium(II)-stabilized carbenoids has been developed. The method allows for an efficient and clean 
conversion of the nucleic acid substrate to a number of singly-, doubly- and triply-modified species. It 
utilizes a simple rhodium(II) precursor, Rh2(OAc)4, and a stabilized -diazocarbonyl compound for 
the in situ generation of the active rhodium(II) carbenoids under mild conditions - aqueous medium at 
ambient temperature and pH close to the physiologically normal one.  
Most importantly, the method provides access exclusively to modification of the exocyclic amino 
groups in adenine, guanine and cytosine without affecting the more nucleophilic heterocyclic nitrogen 
atoms or O-6 in guanine. The regiospecific modification of the exocyclic amines is achieved in a 
structure-selective manner in single-stranded nucleic acid species only, allowing the Watson-Crick 
base pairing to be used as a protective motif. Several examples of nucleic acid labeling with 
fluorescent and biotin tags demonstrate the utility of the method. 
The future work on the rhodium(II) carbenoid system could be continued in several parallel directions: 
(a) Expanding the nucleic acid scope – targeting of longer nucleic acid species (100 bp to several 
kb). This would require development of analytical tools of higher precision and sensitivity in 
order to detect even small changes in the context of a longer DNA or RNA molecule. In this 
sense high resolution mass spectrometry or labeling with specific tags (e.g. biotin) would 
prove invaluable in creating more tractable test systems; 
(b) Expanding the scope of -diazocarbonyl substrates:  
a. Diazo substrates carrying certain tag moieties;  
b. More activated compounds in order to increase the N-H/O-H insertion ratio, thus 
improve the yield of alkylation (e.g. ethyl diazoacetate); 
(c) An in-depth mechanistic investigation of the system. The development of a correct 
mechanistic model for a system with both substrates functioning as potential ligands proved to 
be quite challenging. A reaction assembly with a re-designed diazo substrate that can 
coordinate only through the electron-rich -carbon atom would simplify a further mechanistic 
treatment. An investigation of the pre-catalytic coordination states of the dirhodium catalyst 
would be crucial for such a mechanistic description, as they appear to be detrimental for the 
catalytic process: 
- pre-catalytic complex between rhodium(II) and the nucleobase of the substrate – 
type of coordination (axial or equatorial), stability of the complex, possibilities for 
axial ligand exchange; 
- possibility for equatorial ligand exchange and guanine coordination on the 
reaction time scale and conditions; 
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- a theoretical/computational study – calculation of the individual free energies for a 
small collection of possible pre-catalytic complexes and reaction intermediates. 
This would be particularly valuable in the assessment of the potential rhodium(II) 
coordination states in solution; 
- kinetic investigation of the reaction – determination of the rate-limiting step – loss 
of nitrogen/carbenoid formation or nucleophilic attack on the carbenoid/proton 
shift in the insertion step; 
- influence of the potential coordination states of the catalyst on the sequence-
specificity of the reaction. 
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Chapter 3. Copper(I)-catalyzed insertion reactions in aqueous media 
 
The main goal of the work presented in this chapter is to develop a methodology for the alkylation of 
nucleic acids and simple anilines with copper(I)-stabilized carbenes in aqueous media. The use of this 
approach alone or in a one-pot set-up with CuAAC would provide access to variety of potentially 
significant product structures.  
 
3.1. Alkylation of nucleic acids. Optimization of the reaction conditions and scope with single- 
and double-stranded DNAs and RNAs 
 
The successful implementation of the rhodium(II) carbenoid system for nucleic acid alkylation hinted 
towards the possibility other transition metals to be used for the same purpose. A small screen of 
several transition metal species in an alkylation reaction with the model oligonucleotide d(ATGC) and 
Dz1 identified copper(I) as the most promising candidate for such a catalytic application (Table 4).  
 
Table 4│ Metal catalyst screening for oligonucleotide alkylation.  
Entry Metal Metal source 
Number of alkylation 
products 
Oligonucleotide conversion 
(%)a 
1 Cu(II) CuSO4 8 11 
2 Ag(I) AgBF4 6 3 
3 Co(II) CoCl2 5 3 
4 Ni(II) NiCl2 5 3 
5 Fe(III) FeCl3 5 4 
Reaction conditions: 5 mM oligonucleotide, 1 mM metal source, 50 mM Dz1, 100 mM MES, pH 6.0, 24 h, room 
temperature. a Determined by HPLC-analysis of the reaction mixture.  
 
Initial tests with several copper sources and ligands of both +1 and +2 oxidation states of the metal 
outlined a few important features of the reaction system (Table 5). The addition of a reducing agent 
(sodium ascorbate) to preserve the copper(I) oxidation state proved to be quite beneficial for the 
alkylation reaction. This was in agreement the earlier findings of Kochi78 and Teyssie,60 who had 
shown that copper(I) was the true catalytically active species in copper carbenoid reactions. In the 
cases, where copper(II) was used, it had been reduced in situ by the -diazocarbonyl compound 
present to afford the catalytically active copper(I) species. The two strongly binding bidentate ligands 
1,10-phenanthroline and 2,2ʹ-bipyridyl   seemed to diminish the alkylation efficacy (Table 5, Entries 4, 
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5, 8, 9). This was most likely due to a tighter binding to the copper(I) center and decreasing its affinity 
for the diazo substrate. The triazole ligand THPTA, on the other hand, increased the yield of alkylated 
product. It likely serves the dual roles of stabilizing the copper(I) species in aqueous media and  
scavenging the reactive oxygen species generated by the metal in the presence of ascorbate.86 Such 
products, which would otherwise cause oxidative damage of the nucleic acid species are likely directly 
intercepted by sacrificial ligand molecules on their way out of the inner copper coordination sphere.  
 
Table 5│ Optimization of the reaction conditions for the copper-catalyzed alkylation of d(ATGC) with Dz1  
 
Entry Copper source Ligand 
Addition of 
ascorbate[a] 
Number of alkylation products 
Oligonucleotide 
conversion, %[b] 
(+1) (+2) 
1 CuSO4 - - >7 - 14 
2 Cu(OTf)2 - - 7 - 13 
3 CuSO4 THPTA - >7 - 18 
4 CuSO4 1,10-Phenanthroline - 7 - 6 
5 CuSO4 2,2ʹ-Bipyridyl - 7 - 6 
6 CuSO4 - + 7 >4 47 
7 CuSO4 THPTA + 7 >4 52 
8 CuSO4 1,10-Phenanthroline + 7 >4 36 
9 CuSO4 2,2ʹ-Bipyridyl + 7 >3 30 
Reaction conditions: 5 mM d(ATGC), 1 mM copper(II) source, 1 mM ligand, 50 mM Dz1, 100 mM MES buffer, pH 6.0, 24 
h, room temperature. [a] Copper(I) was generated in situ by addition of 50 mM sodium ascorbate. [b] Determined by  HPLC-
anaylsis of the reaction mixture. 
 
In its final variant the alkylation conditions converged with those for the CuAAC, which would later 
allow carrying out both reactions concurrently. The potential of the copper(I) carbenoids for nucleic 
acid alkylation was demonstrated on a small series of short and medium-sized oligonucleotides (Table 
6). Alkylation of the model oligonucleotide d(ATGC) was a lot more efficient than with the 
rhodium(II) system, as conversions of up to 70 %, accompanied by the formation of over twelve 
alkylation products were observed (Table 6, Entry 1). A more detailed HPLC/MS-analysis of the 
reaction mixtures revealed the presence of even triply-modified products (Figure 17).  
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The three trinucleotides d(TCT), d(TAT), and d(TGT), were used to probe the reaction’s 
regioselectivity and the behavior of the individual nucleic acid structural elements. Apart from the 
almost two-fold increase in the oligonucleotide conversion, the alkylation pattern of d(TAT) with 
copper(I) was identical to that with rhodium(II). The modification of d(TGT) on the other hand 
showed some considerable differences to the rhodium(II)-catalyzed reaction. 
 
Table 6│ Scope of copper(I) nucleic acid alkylation with Dz1. 
Entry Oligonucleotide sequence 
Number of alkylated species Oligonucleotide 
conversion, %[a 
Retained 
oligonucleotide, %[b (+1) (+2) (+3) 
1 d(ATG C) 7 4 1 70 >77 
2 d(TAT) 2 - - 37 >87 
3 d(TGT) 4 1 - 46 >74 
4 d(TCT) 4 - - 27 >85 
5 d(TTT T) 7 1 - 19 >76 
6[c d(ATG) 3 2 2 61 - 
7 r(ACU GCU C) >11 - - 67 - 
8[d[e d(CGA ACG TTT TTC GTT CG) 2 - - 9 - 
9[d[e d(CGA ACG TTT TTC GTT CGA) 4 - - 16 - 
10[d[e d(CGA ACG TTA TTC GTT CG) 6 - - 16 - 
Reaction conditions: 5 mM oligonucleotide, 0.5 mM CuSO4, 2.5mM THPTA, 50 mM Dz1, 10 mM sodium ascorbate, 100 
mM MES buffer, pH 6, 24 h, room temperature. [a Determined by HPLC-analysis of the reaction mixture. [b Determined 
for entries 1-5: total peak area of all oligonucleotide species after the alkylation reaction as a percentage of the peak area of 
the starting oligonucleotide. [c 5 mM sodium ascorbate.  [d Reaction time 48 h. [e Forms a hair-pin structure in solution. 
 
First, d(TGT) was efficiently targeted in the absence of other oligonucleotides. Second, in addition to 
the first set of monoalkylated species, already seen with rhodium(II), the formation of a second set of 
reaction products, as well as some doubly-alkylated oligonucleotide was observed (Figure 18A). A 
second pair of alkylated oligonucleotides was also found in the d(TCT) reaction, although their 
amount was significantly lower than in the case of d(TGT) (Figure 18B). Tandem MS analysis of 
these products revealed the second reaction site was again located on the nucleobase. The ion for the 
doubly-alkylated guanine base was directly observed in the MS/MS analysis of the product from the 
d(TGT) doubly-alkylated fraction (Figure 19). The second modifications most likely occurred at the 
heterocyclic nitrogen atoms N-3 in cytosine and N-1 in guanine, or on the carbonyl oxygens, O-2 and 
O-6 respectively, in the enol forms of the bases (Scheme 48). Attempts for isolation of these products 
from the d(TCT) reaction mixture were unsuccessful, as they were not sufficiently stable and seemed 
to convert to the other two species, already seen in the rhodium(II) alkylation. 
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The next small oligonucleotide tested was d(ATG). Alkylation with Dz1 in the presence of copper(I) 
resulted in several singly-, doubly-, and triply-modified products, consistent with monoalkylation of 
the adenine and mono- and double alkylation of the guanine (Table 6, Entry 6). 
 
A 
 
B 
 
 
Figure 17│ HPLC-separation of the reaction mixture from the copper(I)-catalyzed alkylation of d(ATGC) with Dz1. HPLC-
separation at pH 7.0 (A) and 6.5 (B). The number for each peak indicates the mass from ESI-MS the number in parenthesis 
indicates the number of alkylations per molecule of oligonucleotide. 
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Figure 18│ HPLC-separation of the reaction mixture from the copper(I)-catalyzed alkylation of d(TCT) (A) and d(TGT) (B) 
with Dz1. The number for each peak indicates the mass from ESI-MS, the number in parenthesis indicates the number of 
alkylations per molecule of oligonucleotide. 
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Figure 19│ ESI-MS (A) and MS/MS analysis (B) of the doubly-alkylated product of d(TGT) with Dz1 in the presence of 
copper(I).  
RNA also proved to be a viable substrate for carbene insertion (Table 6, Entry 7). Its extensive 
alkylation producing a number of singly-modified product species clearly demonstrates the capacity of 
the copper(I)-system for RNA-tagging.  
As expected the reactivity of the thymine tetramer was quite modest, resulting in the formation of a 
number of singly-modified species at an oligonucleotide conversion of 19 % (Table 6, Entry 5). In 
comparison to the rhodium(II) method, however, such a result demonstrates the significantly higher 
reactivity of the copper(I) carbenoids, delivering substrate conversion even in the absence of potent 
nucleophiles on the bases. In this case O-2 and O-4 on the thymine bases or the backbone phosphates 
could be the potential alkylation targets. Consistent with that observation, modest alkylation yields 
were obtained with a hair-pin structure with no unpaired reactive bases (Table 6, Entry 8). The 
observed conversion of 9 % is likely due to targeting nucleotide units in the hair-pin loop. Exposing a 
reactive base (adenine) as a 3′-overhang (Entry 9) or in the loop region (Entry 10) led to an almost 
two-fold increase in the alkylation efficiency. 
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Scheme 48│ Comparison of the regioselectivity of the rhodium(II) and copper(I) nucleic acid alkylation systems. In addition 
to the alkylation products observed with the rhodium(II) system several other pootential reaction sites are likely to be targeted 
in the case of  copper(I) carbenoid reactions. 
 
 
The beneficial effect of the THPTA ligand in decreasing the loss of oligonucleotide due to oxidative 
degradation was once more demonstrated with the recoveries measured for some of the small 
oligonucleotide substrates (Table 6, Entries 1-5). An optimization of the catalyst in order to further 
decrease the nucleic acid oxidative damage would bring even more utility to the otherwise quite 
efficient alkylation system. 
 
 
3.2. Alkylation of simple arylamines in aqueous media 
 
The efficacy of the copper(I)-catalyzed NH-insertion reaction with such complex molecules as DNA 
and RNA oligonucleotides led to the belief that it would also be of a value for small molecule 
applications. Moreover, the reaction can be carried out in water which makes it even more attractive 
considering the development of green technologies. 
The N-H insertion with Dz1 and a number of aniline substrates in aqueous media turned out to be 
remarkably fast and efficient, leading to almost complete conversion of the initial substrates at 
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reaction times ranging from minutes to a few hours (Table 7, entries 1-9). The individual reactivity of 
the anilines seemed to have little dependence on their electronic properties (Entries 1, 3-7).  
 
Table 7│ Scope of copper(I)-catalyzed N-H insertion of Dz1 with nitrogen nucleophiles. 
 
Entry Product RX-H pKa[a] 
Reaction 
time, h 
Conversion, 
% 
Ratio 
products 
mono:di[b] 
Isolated yield 
monoalkylation, 
% 
1 53a 
 
4.60 0.25 >99 97:3 85 
2 53b 
 
4.85 0.25 >99 - 82 
3 53c 
 
5.36 1 >99 94:6 75 
4 53d 
 
3.99 0.5 >99 98:2 77 
5 53e 
 
2.50 0.25 >99 99:1 70 
6 53f 
 
2.45 0.25 >99 99:1 74 
7 53g 
 
2.76 0.25 >99 99:1 74 
8 53h 
 
6.71 20 >99 99:1 51 
9 53i 
 
6.03 20 >99 99:1 76 
10 - 
 
10.57 24 <2 
- 
- 
11 - 
 
11.05 24 <2 
- 
- 
12 - 
 
11.12 24 <2 
- 
- 
13 - 
 
6.99 24 <2 - - 
[a] pKa of the singly-protonated cations at 25°C in aqueous solution. [b] For the NH2R nucleophiles a second alkylation on 
the nitrogen is possible. The ratio mono-/dialkylation was determined from the integration areas for the 230-nm absorbance 
peaks in the UPLC-MS analyses of the crude reaction mixtures. 
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The catalytically active copper(I) species is easily prepared from a water-soluble copper(II) source, 
e.g. copper(II)sulfate, chloride or triflate, and sodium ascorbate without the use of any special ligands 
or additives. That, together with the low catalyst loadings (1 mol%), makes the reaction cost efficient 
for process applications, where catalyst economy, operational simplicity and the use green solvents, in 
this case a 4:1 (v/v) mixture of water and tert-butanol, are highly desirable. This approach also 
provides a tool for a strict selection of aromatic over aliphatic amines, as the latter proved to be 
completely unreactive under the conditions employed (Table 2, entries 10-12). This could be 
explained with the protonation state of the N-H group, as at pH 6 the three aliphatic amines tested are 
almost entirely protonated due to the higher pKa values of the conjugate acids, thus a lot less 
nucleophilic. Several important features of the copper(I) system were discovered upon a more rigorous 
investigation of the reaction mixtures. First, all primary arylamines delivered a small amount of 
doubly-alkylated product, as more electron-rich anilines seemed to favor its formation (Table 7). 
Second, small amounts of O-H insertion products with water and ascorbate were found. The 
possibility for targeting alcohols was further examined with 1-butanol, ethylene glycol and phenol, but 
no insertion products were detected for any of these substrates. In that sense the reactivity of the water 
can be explained with its large excess in the reaction system. In the case of ascorbate the quite acidic 
O-H group at C-3 (pKa 4.25) is to be considered as a potential reaction site.94  
Strongly coordinating Lewis basic substrates (imidazole (Table 7, Entry 13), 2-
(diethylamino)ethanethiol) completely blocked the catalytic activity of copper(I), as neither formation 
of the respective X-H insertion products, nor products from the side-reactions of O-H insertion in 
water and ascorbate were detected.  
Establishing a mechanistic model for the functioning of the copper(I) cabenoid insertion proved to be 
complicated even for the reaction with small anilines. The main problem was the presence of multiple 
coordination states of the catalytically active copper(I) species. The copper(I) complex should have a 
tetrahedral geometry with four coordinating ligands. In the present reaction system water, ascorbate, 
THPTA, as well as the diazo substrate can bind to the metal center. In addition, attempts to correlate 
the initial rates of Dz1 consumption with the aniline concentration in a reaction of N-H insertion did 
not show a Michaelis-Menten type saturation kinetics. Instead a clear effect of substrate inhibition was 
observed at concentrations above 10 mM, which indicated coordination of the aniline substrate to the 
copper catalyst (Figure 20).  
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Figure 20│Dependence of the initial rate of Dz1 conversion on the aniline concentration in a Cu(I)-catalyzed N-H insertion 
in aniline. Reaction conditions: 25 M CuSO4, 12.5 mM Dz1, 20 mM sodium ascorbate, 200 mM MES buffer, pH 6.0.  
 
 
3.3. Tandem auto-catalytic Cu(I)-catalyzed azide-alkyne cycloaddition/N-H insertion. 
Biomolecular labeling applications 
 
Apart from its efficiency of aniline alkylation with carbenoids, a great advantage of the copper(I) 
catalytic system is the possibility for its multi-purpose use. The active catalytic species could be 
utilized for carrying out several concurrent transformations in a more economic one-pot set-up, 
achieving a greater product diversity with just a single purification step.  
 
Table 8│ Auto-tandem catalytic CuAAC/N-H insertion with small molecule substrates 
 
Reaction conditions: 0.5 mM CuSO4, 50 mM amine, 50 mM diazo substrate, 55 mM azide, 35 % (v/v) tBuOH, 24 h, room 
temperature. 
68 
 
The utility of the CuAAC in both chemical library construction and macromolecular conjugation 
makes it an ideal candidate for complementing the N-H insertion protocol in a concurrent reaction set-
up. A tandem copper(I)-catalyzed N-H insertion/CuAAC was first demonstrated on small molecule 
substrates (Table 8). The two examples shown differ by the degree of complexity of the azide moiety 
and the location of the alkyne group. The tandem processes worked well in both cases with very good 
yields of the isolated ‘click’/insertion products 55 and 56. Since copper(I) tends to form rather stable 
complexes with alkynes, it is important to use a slight excess of the azide component in order to insure 
complete conversion of the alkyne and make the catalyst available for the insertion reaction. 
The ultimate task at hand was achieving nucleic acid tagging through copper(I)-catalyzed tandem 
‘click’/N-H insertion. In order to do that the alkyne moiety for the copper ‘click’ reaction was installed 
on the diazo compound, which in this case would be the connecting element between the 
oligonucleotide and the appropriately functionalized azide. A propargyl ester analogue of Dz1 was 
prepared as shown on Scheme 49. Esterification of the commercially available 4-
(bromomethyl)phenylacetic acid with a small excess of propargyl alcohol according to the modified 
protocol of Clinton and Laskowski,95 followed by substitution of the benzylic bromide with dimethyl 
amine and installation of the diazo group via nucleophilic diazo transfer afforded the final compound 
Dz6 (57) in a 55 % yield over three steps. 
 
 
Scheme 49│ Synthetic scheme for preparation of Dz6 (57). 
 
The tandem CuAAC/N-H insertion with Dz6 and the two azides 47 and 54 was tested on three short 
DNA oligonucleotides, using the reaction conditions for the nucleic acid alkylation with copper(I)-
carbenoids. The CuAAC reaction appeared to be quite efficient and quick, as in all cases the 
modification products detected also carried the ‘click’ tag.  
The modification of d(ATG) with Dz6 and 3-azidopropan-1-ol yielded a number of singly-, doubly-, 
and triply-tagged products at a conversion of 80 % after 18 h (Figure 21). Tandem MS analysis 
showed the presence of ‘click’/alkylated guanine base in all product fractions and modified adenine 
only in the triply-alkylated species. This indicates that guanine was the primary alkylation target, 
undergoing two consecutive modifications before adenine could be targeted. In addition to that some 
singly-alkylated products with a hydrolyzed ester moiety were observed. 
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The G-rich sequence d(GGA GGC) was modified as described for d(ATG). An RP-HPLC-analysis of 
the reaction mixture under the standardly used neutral conditions yielded quite a poor peak shape and 
separation (Figure 22). Such deviations in the chromatographic behavior had been previously observed 
with other G-rich sequences and were most likely due to intermolecular association effects. The 
modification itself was quite efficient, as a number of product species with up to four ‘click’/N-H 
insertion groups per molecule of oligonucleotide were detected. An oligonucleotide conversion of 
roughly 60 % was determined on the base of the peak area, although a precise estimate could not be 
made due to the presence of non-modified starting oligonucleotide in all fractions (Figure 23).  
 
 
 
 
Figure 21│HPLC analysis of the reaction mixture of the tandem CuAAC/N-H insertion labeling of d(ATG) with Dz6 and 3-
azidoprop-1-ol. The fractions were identified by ESI-MS analysis (the masses are given for each peak). The number and type 
of modification is indicated in parenthesis. Alk-Me: singly-modified species with hydrolized ester group (only acyl portion 
remaining). 
 
The modification of d(ATGC) with Dz8 and biotin azide 47 resulted in a lot cleaner product mixture 
with up to two ‘click’/N-H insertion modifications per oligonucleotide molecule detected (Figure 24). 
The overall oligonucleotide conversion was lower than for the example with d(ATG). As pointed out, 
CuAAC between Dz6 and biotin azide 47 should be the first reaction to take place and should result in 
the in situ formation of the diazo compound 57.  
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Subsequent DNA modification with the respective copper(I)-stabilized carbenoid was most likely 
hindered by the sterically demanding alkyl ester portion. The increased steric bulk was also likely the 
reason for the lack of detectable amounts of products with higher modification numbers. 
 
 
 
 
 
Figure 22│HPLC analysis of the reaction mixture of the tandem CuAAC/N-H insertion labeling of d(GGA GGC) with Dz6 
and 3-azidoprop-1-ol. The fractions were identified by  MALDI-TOF MS. The number and type of modification is indicated 
in parenthesis. Alk-Me: singly-modified species with hydrolized ester group (only acyl portion remaining). 
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Figure 23│ MALDI TOF of the products from the tandem’click’/alkylation reaction of d(GGA GGC) with Dz6 and 3-
azidoprop-1-ol. The number and type of modification is indicated in parenthesis. 
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Figure 24│HPLC analysis of the reaction mixture of the tandem CuAAC/N-H insertion labeling of d(ATGC) with Dz6 and 
biotin azide 47. The fractions were identified by MALDI-TOF MS (the masses are given for each peak). The number of 
modifications are indicated in parenthesis. 
 
An interesting point with respect to the potential labeling applications of the method is its ability to 
target proteins or, more importantly, the ability to modify nucleic acids in the presence of proteins 
(e.g. in cell lysates). This was tested with three proteins, BSA, lysozyme and wild-type streptavidin, 
which were present at a 1 mM concentration in a standard d(TAT) alkylation reaction with Dz1 as 
described in Section 3.1. Lysozyme and streptavidin did not significantly affect the oligonucleotide 
alkylation efficiency or the overall catalyst reactivity as judged from the conversions of d(TAT) and 
the Dz1 (Table 9). The presence of BSA on the other hand significantly decreased the catalytic 
acitivity and almost completely blocked the oligonucleotide alkylation reaction. This means that 
although suitable for some in vitro appplications the method has to be examined in terms of feasibility 
on a case-to-case basis to exclude possible interference of other components of the system.    
 
Table 9│ Cu(I)-Catalyzed alkylation of d(TAT) with Dz1 in the presence proteins 
Entry Protein Conversion of d(TAT), % Conversion of Dz1, % 
1 - 41 89 
2 Bovine serum albumin <1 32 
3 Lysozyme 37 91 
4 Streptavidin (wild type) 33 82 
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3.4. Conclusions and future directions 
 
A catalytic system for arylamine alkylation based on N-H insertion of copper(I)-stabilized carbenoids, 
has been developed. The catalyst is conveniently prepared in situ from a copper(II) salt and a reducing 
reagent and utilized under the standard conditions for CuAAC. A wide scope of arylamine substrates 
ranging from simple anilines to nucleobases on short DNAs and RNAs has been efficiently targeted, 
achieving high substrate conversions. The enhanced reactivity of the copper(I) carbenoids towards 
nucleic acid substrates allows for multiple targeting, especially in guanine-containing substrates, 
making the method suitable for biomolecular tagging. On the other hand the efficiency with anilines in 
aqueous media and the strict selection for aromatic over aliphatic amines suggests potential 
applications in synthetic chemistry. The complete convergence of the reaction conditions with those 
for CuAAC allowed copper ‘click’ chemistry to be combined with copper(I) cabenoid N-H insertion in 
an auto-catalytic tandem process. Such a convenient one-pot set-up provides direct access to a number 
of diverse structures for small molecule library applications requiring only a single purification step at 
the end. It could also be used for direct DNA and RNA tagging with an alkyne-bearing diazo substrate 
as a linker unit for coupling the nucleic acid with a certain azide-modified marker. 
A continuation of this study should address several questions of potential fundamental and practical 
value: 
(a) Determination of the regioselectivity of nucleobase targeting – revealing of the position of the 
second alkylation in the case of guanine and cytosine; 
(b) Copper(I) coordination states - formation and catalytic activity of Cu(I)/nucleic acid and 
Cu(I)/aniline complexes;  
(c) Reactivity of copper(I) carbenoids on longer DNAs and RNAs. As with the rhodium(II) 
catalytic system this would require analytical methods of higher sensitivity and precision; 
(d) Development of an asymmetric version of the aniline alkylation system – screen and design of 
chiral copper(I) ligands for use under aqueous conditions; 
(e) Implementation of the system in the context of a sequence-specific nucleic acid alkylation. 
Combined with a further optimization of the reaction conditions in order to suppress the 
nucleic acid oxidative damage, such a system would be of a great utility for some complex 
chemical biology applications.  
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Chapter 4. Direct reversal of DNA alkylation with AlkB dioxygenase from E.coli 
 
Cell DNA is constantly subjected to modifications by both endogenous and exogenous agents. In some 
cases these modifications are important for essential processes such as regulation of the DNA 
replication and transcription. In other cases, especially for reagents coming from the environment, 
such nucleic acid modifications could be toxic or mutagenic. In this sense DNA repair is an essential 
mechanism for insuring proper cell functioning. One such type of DNA repair is the direct repair, in 
most cases known this is the direct reversal of DNA alkylation damage. There are several proteins 
known to perform such a direct alkylation reversal: the N-Ada protein in E.coli, the O6-alkylguanine-
DNA alkyltransferase family and the AlkB family. An outline of the most common types of DNA 
alkylation damage and the respective enzymes for their direct repair is shown in Scheme 50.37  
 
 
 
Scheme 50│ Typical types of DNA damage observed with SN2 and SN1 alkylating reagents. The fraction of the particular 
alkylation damage together with the respective enzyme for direct repair are indicated for each site in single- and double-
stranded DNAs.    
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The present study focuses on DNA dealkylation catalyzed by AlkB. AlkB is an iron(II)/-
ketoglutarate dependent dioxygenase, which is responsible for removal of alkylations mainly from N-1 
of adenine and N-3 of cytosine. A plausible mechanism for its catalytic action is shown in Scheme 51. 
The iron(II) species involved in the catalysis is directly ligated to His131, Asp133 and His187 of the 
enzyme active site, as well as to an -ketoglutarate anion.  
 
 
 
Scheme 51│ Plausible mechanism for the direct repair of N-akylated DNA nucleobases by the dioxygenase AlkB from 
E.coli. The mechanism shown is for dealkylation of cytosine base. The N3-hydroxyalkylcytosine breaks down further to yield 
the respective aldehyde and the unmodified nucleobase.   
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The catalytic cycle starts with coordination of molecular oxygen to the iron(II) center to form an 
iron(III)-bond superoxide anion radical. The superoxide anion radical then forms a bridged peroxo-
type intermediate with the C-2 of the -ketoglutarate and the iron center (now oxidized to iron(IV)). 
Decarboxylation of this intermediate accompanied by a polar cleavage of O-O-bridge gives a 
succinate anion and the key iron(IV)-oxo intermediate. This species abstracts a hydrogen radical from 
the nucleic acid substrate -N-alkyl carbon to give an N-alkyl radical and an iron(III)-hydroxyl 
species. A subsequent hydroxylation of the N-alkyl radical yields an N-hydroxyalkyl nucleobase, 
regenerating the iron(II) center. The N-hydroxyalkyl derivative breaks down to an alkyl aldehyde and 
the unmodified base. Several different elements of the nucleic acid substrate structure proved to be 
important for the dealkylation reaction. The requirement for a 5′-phosphate which most likely assists 
the proper positioning of the substrate is the first one.96 The smallest efficiently dealkylated substrate 
was found to be 1-methyl-2′-deoxyadenosine-5′-monophosphate, while the respective 3′-
monophosphate and 5′-triphosphate were quite poorly converted mainly due to impaired binding. 
Concerning the nucleobase alkylations at N-1 of adenine and N-3 of cytosine are the primary targets, 
although N-3 in thymine and N-1 in guanine could also be repaired.97  
So far damage reversal by AlkB has been shown only for N-methyl derivatives of the four canonical 
DNA bases, as well as for N3-ethyl cytosine97 and two bicyclic cytosine derivatives, 3,N4--
hydroxyethanocytosine (58) and 3,N4-ethenocytosine (59).98 Studies on the repair of propyl, 
hydroxyethyl and hydroxypropyl modifications have only been done in vivo with poorly defined 
nucleic acid substrates.96      
 
 
The objective of the work in this chapter is to extend the variety of N-alkyl groups on 2′-
deoxynucleoside substrates repaired by AlkB from E.coli and to optimize the substrate structure in 
order to increase the efficacy of repair. Such system could then be used for in vitro and in vivo 
removal of previously installed alkyl moieties, bearing various tags and markers (on-demand tag 
removal). Our test concept was that if the cargo was attached to the DNA through a medium-sized or a 
long alkyl group spacer it should remain outside the catalytic pocket of the enzyme, thus its steric bulk 
would have less interference on the repair process.                    
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4.1. Direct alkylation of mononucleoside-5′-monophosphates 
N1-adenine and N3-cytsine alkylated substrates for the reversal repair study were prepared by 
treatment of the corresponding 2′-deoxynucleoside 5′-monophosphates with alkyl bromides or iodides 
as already described for N1-isopentenyladenosine.99 The reactions were carried out in DMSO at room 
temperature varying the amount of alkylation reagent and the reaction time. The procedure worked 
well only for the adenine N-1 alkylation with methyl iodide, where a pure product in a very good yield 
(80 %) was isolated already after the initial work up. In all other cases less than optimal conversions 
(<50 %) were observed and attempts to improve them by increasing the amount of alkylation reagent 
led to the formation of doubly-modified products by targeting the 5′-phosphate. The alkylation was 
more efficient for the conjugated alkyl bromides (allyl, propargyl, cis- and trans-2-hexenyl) and 
shorter reaction times were required to achieve moderate substrate conversions. The rather 
complicated purification, however, resulted in isolated yields of the target product of not more than 10 
%. 
 
4.2. Expanding the substrate scope of AlkB: direct enzymatic removal of bulky N-alkyl groups 
from nucleoside-5′-monophosphates  
The direct dealkylation catalyzed by AlkB was tested on a small series of adenine and cytosine 
derivatives with varying length and structure of the N-alkyl group (Scheme 52) under conditions 
similar to those described earlier.100  
 
 
 
Scheme 52│ Scope of N-alkylated 2′-deoxyadenine and 2′-deoxycytidine 5′-monophosphates tested in a dealkylation 
reaction with AlkB.        
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Previous kinetic studies on catalytic repair of several small N-methylated adenine-containing 
derivatives with AlkB showed KM-values of up to 50 M even for the poorest substrates.96 Based on 
that the activity measurements were carried out with 1 mM initial concentration of the alkylated 
substrate to insure a zero-order behavior of the system with respect to it. The obtained reaction rate 
values were compared to that for the reference substrate 60a under equal other conditions.  
The simple increase in the length of the N1-alkyl chain as in the case of N1-n-butyladenine resulted in  
poor dealkylation rates with less than 10 % overall substrate conversion after 24 h incubation with the 
enzyme. The enzyme was also unable to repair alkylation at N-6 of adenine as demonstrated in 
experiments with compound 60b.  
Since the mechanism of dealkylation most likely involves a radical hydroxylation of the N-alkyl -
carbon (Scheme 51), alkyl groups that could stabilize a radical at that position should be removed 
more efficiently. Indeed, tests with the N1-allyl-2′-deoxyadenosine derivative 60d showed that its 
AlkB-catalyzed repair was two-fold faster than that of the reference substrate 60a. Consistent with that 
the N3-propargyl group in the cytidine derivatives 61b and 61c was also readily removed. In the same 
time the 5′-O-alkylation in 61c had a negative effect on the dealkylation, which was more than two-
fold slower than that for compound 61b. 
The possibility to exploit the 2,3-double bond motif in both cis- and trans-configuration for increasing 
the efficiency of removal of longer alkyl chains was tested with adenine derivatives 60e and 60f. Both 
substrates displayed quite a slow dealkylation delivering less than 10 % conversion after 24 h 
incubation with the enzyme. On the other hand the N3-(cis-2-hexenyl)-2′-deoxycytidine derivative 61a 
showed significantly higher propensity for enzyme repair, as 10 % substrate conversion was achieved 
in less than an hour reaction time. This might be a result of decreasing the base size, thus facilitating 
the substrate binding in the enzyme active site.          
Finally, a dealkylation reaction was attempted on the sterically demanding substrate 61d bearing a 
triazole-containing N3-alkyl moiety. The increased bulk in a close proximity of the nucleobase was 
most likely the reason for the lack of detectable delakylation of this substrate. This result once more 
confirms the need for a linker in case functionalization with larger cargo molecules is desired. 
An activity comparison of the best substrates for AlkB is outlined in Scheme 53. 
 
 
 
79 
 
 
 
Scheme 53│ Scope of the N-modified 2′-deoxyadenine and 2′-deoxycytidine 5′-monophosphates dealkylated by AlkB. 
Reaction rates from the activity assays [M.min-1] are given in parenthesis. Assay conditions: 1 mM alkylated nucleoside 
monophosphate, 2 mM -ketoglutarate, 100 M FeSO4, 2 mM sodium ascorbate, 2 mM DTT, 50 mM KCl, 100 g.ml-1 
BSA, 50 mM Tris-HCl, pH 8.0, 7.44 M AlkB, 37°C.         
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4.3. Conclusions and future directions 
 
The scope of N-alkylated adenine and cytosine substrates for the dioxygenase AlkB from E.coli has 
been expanded, as the enzyme was shown to efficiently remove small and medium-sized conjugated 
N-alkyl moieties. Such direct repair is likely favored by the ability of such functionalities to stabilize 
carbon radicals, thus facilitating the radical hydroxylation step of the enzyme reaction. The possibility 
larger tags connected to a nucleobase of the DNA substrate through a suitable linker to be 
enzymatically removed is demonstrated with the dealkylation of N3-(cis-2-hexenyl)-2′-deoxycytidine-
5′-monophosphate. However, some more detailed studies are needed to fully assess the system 
properties and define more precisely its possible practical applications: 
(a) Optimization of the activity assay to improve the enzyme stability – concentration of the 
iron(II) source, use of TCEP instead of DTT; 
(b) Activity tests with an optimized version of the N3-alkylated 2′-deoxycytidine-5′-
monophosphate substrate: dealkylation efficiency with a C5-C7 alkyl chain substrates 
containing a 2,3-alkyne group; enzymatic removal of the same functionalities with an attached 
cargo (rhodamine, biotin, etc.); 
(c) Determination of the steady-state kinetic parameters for the AlkB-catalyzed dealkylation of 
substrates 60d and 61b: separation of the kinetic constants kcat and KM would clarify if the 
respective C3-moieties improve the substrate binding or the catalytic step of the enzymatic 
reaction. An increase in the turnover number kcat would be an indirect evidence for the 
involvement of a radical species in the catalytic process as suggested by the widely accepted 
mechanism for the enzyme action; 
(d) Enzyme activity tests with short oligonucleotides of the type d(TTCTT), where cytosine is N3-
alkylated – dependence of the dealkylation efficacy on the substrate base length. 
(e) Enzymatic repair of N1- and N2-alkylated guanine derivatives.   
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Chapter 5. Experimental 
 
5.1. General 
All reagents and solvents used were of analytical grade. Buffers were prepared with ultrapure water. 
All chemicals were purchased from Sigma-Aldrich, Fluka or Acros and were used as received. 
Analytical TLC was performed on Silica gel 60 F254 pre-coated aluminium sheets. Flash 
chromatography was performed on Silica gel 60 40-63 m (230-400 mesh) (SiliCycle, Quebec).  
Solid-phase oligonucleotide synthesis was carried out on an Expedite 8909 nucleic acid synthesis 
system (PerCeptive Biosystems). Phosphoramidites for DNA synthesis (ABz, Gdmf, CAc, T) were 
purchased from Proligo Reagents, SAFC. SynBase 500/110 AllFit pre-modified oligonucleotide 
synthesis columns, Acetonitrile anhydrous wash, BTT activator, CapA, CapB and Oxidizer for the 
Expedite device, as well as 2′-O-TBDMS-protected RNA phosphoramidites (ABz, Gdmf, CAc, T) were 
purchased from Link Technologies.  
1H, 13C and 31P NMR spectra were acquired on a Bruker Avance III 600 MHz, Bruker Avance III+ 500 
MHz and Bruker Avance III 400 MHz spectrometers at 298 K. 19F NMR spectra were measured on a 
Bruker AvanceIII 400 MHz spectrometer at 298 K. Chemical shifts relative to TMS were referenced 
to the solvent’s residual peak and are reported in ppm.  
ESI MS spectra were obtained on a Bruker Esquire3000plus spectrometer by direct injection in 
positive polarity of the ion trap detector. Tandem MS spectra were measured on the same device after 
collision-induced dissociation with molecular nitrogen. High resolution mass spectra were acquired on 
a Bruker maXis 4G QTOF ESI mass-spectrometer. EI MS were obtained on a Finnigan MAT 95 
device. MALDI TOF analyses were carried out on a Bruker Microflex mass spectrometer in linear 
negative mode using the following matrixes: 3-hydroxypicolinic acid/ammonium citrate buffer, pH 6.0 
(for oligonucleotides with Mr > 3000) or 2,4,6-trihydroxyacetophenone/ammonium citrate buffer, pH 
6.0 (for oligonucleotides with Mr < 3000). IR spectra were obtained on a Bruker ALPHA FT-IR 
spectrometer.   
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5.2. HPLC 
Analytical HPLC analyses were carried out on an Agilent 1100 LC system equipped with a 
Chromolith Performance RP18e 4.6 × 100 mm column (Merck) using methods A, B, C or D or with 
an Eclipse XDB-C18 4.6 × 150 mm column (Agilent), using method E or F.  
Method A: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 7.1)/acetonitrile gradient 0-16 
% acetonitrile in 12 min, 16-80 % acetonitrile in 3 min, 80 % acetonitrile in 2 min. 
Method B: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 7.1)/acetonitrile gradient 0-16 
% acetonitrile in 12 min, 16-80 % acetonitrile in 15 min, 80 % acetonitrile in 2 min.  
Method C: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 7.3)/acetonitrile gradient 0-16 
% acetonitrile in 12 min, 16-80 % acetonitrile in 3 min, 80 % acetonitrile in 2 min.  
Method D: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 6.0)/acetonitrile gradient as in 
method A.  
Method E: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 7.3)/acetonitrile gradient 0-16 
% acetonitrile in 18 min, 16-80 % acetonitrile in 4.5 min, 80 % acetonitrile in 3 min. 
Method F: Flow rate 1 ml/min, 100 mM triethylammonium acetate (pH 7.1)/acetonitrile gradient 0-3 
% acetonitrile in 4 min, 3-80 % acetonitrile in 4 min, 80 % acetonitrile in 1 min.  
In all methods detection was done by monitoring the absorbance of the column effluent at 254 nm.  
UPLC-MS was carried out on a Agilent 1290 Infinity system, equipped with a Zorbax Eclipse Plus 
C18 2.1 × 50 mm column (Agilent), coupled to an Agilent 6130 Quadrupole LC/MS. Elution was 
done with 0.1 % trifluoroacetic acid in water/acetonitrile system at a flow rate of 0.2 ml/min using 
method D: 0-54 % acetonitrile in 4 min, 54-95 % acetonitrile in 1 min, 95 % acetonitrile in 1 min, 
detection at 230 and 254 nm, and with ESI-MS in positive ion mode of the ion trap.  
Semi-preparative HPLC was carried out on a Shimadzu VP Liquid Chromatograph using a 
LiChroCART 10 × 250 mm cartridge, packed with Purosphere®STAR RP-18e 5 m (Merck). Elution 
was done at a flow rate of 5 ml/min in a 100 mM triethylammonium acetate (pH 7.1)/acetonitrile 
gradient 0-16 % acetonitrile in 15 min, 16-80 % acetonitrile in 20 min, 80 % acetonitrile in 2 min. 
Detection was done by monitoring the absorbance of the column effluent at 254 nm. 
Preparative HPLC was carried out on a Shimadzu Prominence Preparative Liquid Chromatograph 
using a Gemini C18 10 m 21.2 × 250 mm column (Phenomenex). Elution was done at a flow rate of 
20 ml/min in water/acetonitrile gradient 0 % acetonitrile in 3 min, 0-40 % acetonitrile in 27 min, 40-95 
% acetonitrile in 5 min, 95 % acetonitrile in 5 min. Detection was done by monitoring the absorbance 
of the column effluent at 254 nm. 
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5.3. Chemical synthesis 
 
Compound 11 was prepared as described by Antos and Francis,54 THPTA – as described by Finn et 
al.86  
 
Methyl 2-(4-(bromomethyl)phenyl)acetate (36). 4-(Bromomethyl)phenylacetic acid (0.2 g, 0.87 
mmol) was mixed with dry methanol (2 ml) and dry benzene (2 ml) under 
nitrogen. Trimethylsilyldiazomethane (2 mol/l in hexanes) was added drop-wise 
at continuous stirring until stable yellow color of the solution was obtained (the reaction vessel should 
be vented as gas evolution takes place). The mixture was stirred for 15 min at room temperature, then 
evaporated and dried under high vacuum to yield the pure compound as a colorless oil (0.21 g, 0.86 
mmol, quant.). TLC (n-hexane:Et2O 4:1 v/v) Rf =0.36. 1H NMR (500.1 MHz, CDCl3) , ppm: 7.36 (d, 
J = 8.1 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H), 4.48 (s, 2H), 3.69 (s, 3H), 3.62 (s, 2H). 13C NMR (125.8 
MHz, CDCl3) , ppm: 171.73, 136.68, 134.28, 129.75, 129.31, 52.16, 40.86, 33.21. MS (EI): 104.1 
M-Br-COOMe+, 163.1 M-Br+, 183.0, 185.0 M-COOMe+, 242.0, 244.0 M+. 
 
Methyl 2-diazo-2-(4-((dimethylamino)methyl)phenyl)acetate (37, Dz1). Compound 36 (0.2 g, 0.82 
mmol) was dissolved in 2 ml of absolute ethanol, dimethylamine in absolute 
ethanol (2 ml, 5.6 mol/l) was added and the mixture was stirred at room 
temperature for 30 min. The volatiles were then removed under vacuum and 
the residue was partitioned between ethyl acetate and saturated sodium bicarbonate solution. The 
organic phase was washed with brine, dried with anhydrous sodium sulfate and evaporated under 
vacuum. The remaining yellow oil was dried under high vacuum, and then mixed with p-
acetamidobenzenesulfonyl azide (pABSA, 0.216 g, 0.90 mmol) in 5 ml of dry acetonitrile under 
nitrogen. DBU (0.187 g, 1.23 mmol) was added to the solution with continuous stirring and the 
mixture was stirred for 24 h at room temperature. The mixture was then evaporated under vacuum and 
the residue purified by flash chromatography on Si60 in DCM/methanol to afford a yellow-orange oil 
(0.082 g, 0.35 mmol, 43 %). TLC (DCM:methanol 10:1 v/v) Rf=0.33. 1H NMR (500.1 MHz, CDCl3) 
, ppm: 7.43 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.5 Hz, 2H), 3. 86 (s, 3H), 3.41 (s, 2H), 2.23 (s, 6H). 13C 
NMR (125.8 MHz, CDCl3) , ppm: 165.76, 136.63, 129.74, 124.07, 123.94, 63.87, 52.01, 45.33. MS 
(ESI): Calcd for C12H16N3O2+ M+H+ 234.1, found 234.1. 
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4-((N,N-Dimethylamino)methyl)bromobenzene (39).  4-(Bromomethyl)phenylbromide (0.4 g, 1.6 
mmol) was suspended in 5 ml of absolute ethanol, dimethylamine in absolute 
ethanol (5 ml, 5.6 mol/l) was added and the mixture was stirred at room temperature 
for 30 min. The volatiles were then removed under vacuum and the residue was 
partitioned between ethyl acetate and 1 M NaOH. The organic phase was washed with 1 M NaOH, 
brine, dried with anhydrous sodium sulfate and evaporated under vacuum. The remaining semisolid 
was purified by flash chromatography on Si60 in DCM/methanol to give a yellowish oil (0.24 g, 1.1 
mmol, 70 %). TLC (DCM:methanol 10:1 v/v) Rf=0.30. 1H NMR (500.1 MHz, CDCl3) , ppm: 7.44 (d, 
J = 8.3 Hz, 2H), 7.18 (d, J = 8.2 Hz, 2H), 3.36 (s, 2H), 2.22 (s, 6H). 13C NMR (125.8 MHz, CDCl3) , 
ppm: 138.01, 131.34, 130.72, 120.83, 63.68, 45.34. MS (ESI): Calcd for C9H12BrN+ M+H+ 214.0, 
216; found. 214.0, 216.0. 
 
Methyl 2-diazo-2-(4-((dimethylamino)methyl)phenyl)acetate-2-13C (40). K3PO4.H2O (0.75 g, 3.0 
mmol) was mixed with dry toluene (5 ml) in a pressure tube. Compound 3a′ (0.2 g, 
0.93 mmol), Pd(OAc)2 (0.005 g, 0.002 mmol), 2-di-tert-butylphosphino-2′-
methylbiphenyl (0.010 mg, 0.03 mmol) and ethyl acetoacetate-2,4-13C2 (0.15 g, 1.0 
mmol) were then introduced, the tube was flushed with nitrogen and closed. It was 
then heated up to 80°C and kept at that temperature for 1 h. The temperature was raised to 95°C over 1 
h, and finally the mixture was kept at 105°C for 3 h. After cooling down the mixture was centrifuged, 
the black pellet was washed with 2 x 2 ml of toluene, the organic layers were combined, evaporated 
and dried under high vacuum to yield a reddish-brown oil. The oil was dissolved in dry methanol (1 
ml) and 25 % (w/w) sodium methoxide in methanol (0.5 ml) was added drop-wise. The mixture was 
left at room temperature for 1 h, then DCM (40 ml) was added and the organic layer was washed with 
2 x 30 ml of saturated sodium bicarbonate, dried with anhydrous sodium sulfate, evaporated and dried 
under high vacuum to give a brown oil. The oil was dissolved in dry acetonitrile (10 ml), p-
acetamidobenzensulfonyl azide (0.255 g, 1.1 mmol) and DBU (0.2 g, 1.3 mmol) were then added and 
the mixture was stirred for 24 h at room temperature. It was then evaporated and purified by flash 
chromatography on Si60 in DCM/methanol to yield an orange oil (0.083 g, 0.35 mmol, 38 %). TLC 
(DCM:methanol 10:1 v/v) Rf=0.33. 1H NMR (500.1 MHz, CDCl3) , ppm: 7.41-7.44 (m, 2H), 7.33 (d, 
J = 8.2 Hz, 2H), 3.86 (s, 3H), 3.41 (s, 2H), 2.23 (s, 6H). MS (ESI): Calcd for 12C1213CH16N3O2+ 
M+H+ 235.1, found 235.1. 
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1-(4-(1-Diazo-2-methoxy-2-oxoethyl)phenyl)-N,N,N-trimethylmethanaminium iodide (42, Dz3). 
Compound 37 (0.024 g, 0.1 mmol) was mixed with neat methyl iodide (0.6 
ml, 1.37 g, 9.65 mmol) under nitrogen. The orange oil became light yellow 
and solidified. The mixture was sonicated, then left for 1 h at room 
temperature. After that the unreacted methyl iodide was flushed out with nitrogen and the yellow solid 
was dissolved in acetonitrile-methanol, dried over Si60 and purified in Si60 in DCM/methanol to yield 
bright yellow crystalline solid (0.026 g, 0.07 mmol, 70 %). TLC (DCM:methanol 10:1 v/v) Rf=0.25. 
1H NMR (500.1 MHz, CD3CN) , ppm: 7.65 (d, J = 8.6 Hz, 2H), 7.57 (d, J = 8.5 Hz, 2H), 4.52 (s, 3H), 
3.83 (s, 3H), 3.06 (s, 9H). 13C NMR (125.8 MHz, CD3CN) , ppm: 165.85, 134.28, 130.07, 125.57, 
124.72, 69.33, 69.30, 69.29, 64.32, 53.23, 53.20, 53.16, 52.77. MS (ESI): Calcd for C13H18N3O2+ M + 
248.1, found 248.1. 
 
Methyl 2-diazo-2-(4-(piperazin-1-ylmethyl)phenyl) acetate (44a). 4-(Bromomethyl)- phenylacetic 
acid (0.4 g, 1.75 mmol) was mixed with dry methanol (3 ml) and dry 
benzene (3 ml) under nitrogen. Trimethylsilyldiazomethane (2 mol/l in 
hexanes) was added drop-wise at continuous stirring until stable yellow 
color of the solution was obtained (the reaction vessel should be vented as gas evolution takes place). 
The mixture was stirred for 15 min at room temperature, then evaporated and dried under high vacuum 
to yield the ester as a colorless oil. The oil was dissolved in dry acetontrile (5 ml), and added to a 
stirring mixture of N-Boc-piperazine (0.335 g, 1.8 mmol) and triethylamine (0.182 mg, 1.8 mmol) in 
10 ml of dry acetonitrile under nitrogen. The mixture was stirred until completed as judged by TLC 
(30 min). The volatiles were removed under vacuum, and the residue was dissolved in 
dichloromethane (20 ml), washed with 2 × 20 ml of saturated sodium bicarbonate, dried with 
anhydrous sodium sulfate, evaporated and dried under high vacuum. It was then mixed with p-
acetamidobenzenesulfonyl azide (0.462 g, 1.93 mmol) in 10 ml of dry acetonitrile under nitrogen. 
DBU (0.297 g, 1.93 mmol) was added to the solution with continuous stirring and the mixture was 
stirred for 24 h at room temperature. The mixture was then evaporated under vacuum and the residue 
purified by flash chromatography on Si60 in DCM/methanol to afford a yellow-orange oil. The oil was 
dissolved in dry dichloromethane (10 ml), mixed with freshly filtered through a short pad of Al2O3 
2,6-lutidine (0.811 g, 7.6 mmol), and cooled on ice. Trimethylsilyl trifluoromethanesulfonate (0.85 g, 
3.8 mmol) was introduced drop-wise and the mixture was stirred until complete as judged by TLC. It 
was then evaporated to dryness and the residue was purified by column chromatography on Si60 in 
dichloromethane/methanol to yield the final product as a yellow-brown solid (87 %). 1H NMR (500 
MHz, CD3CN) δ/ppm: 7.50 (d, J = 8.5 Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 3.81 (s, 3H), 3.73 (s, 2H), 
3.27 – 3.21 (m, 4H), 2.87 – 2.76 (m, 4H). 13C NMR (126 MHz, CD3CN) δ/ppm: 165.41, 132.78, 
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130.11, 125.75, 123.98, 60.95, 51.73, 48.78, 43.57. MS (ESI) calcd for C14H19N4O2+: (M + H)+, 
275.22; found: (M + H)+, 275.0. 
Methyl 2-diazo-2-(4-((4-(prop-2-yn-1-yl)piperazin-1-yl)methyl)phenyl) acetate (44, Dz4). 
Compound 44a (80 mg, 0.29 mmol) was mixed with N,N-
diisopropylethylamine (0.113 mg, 0.86 mmol) and 80 % (w/w) 
propargyl bromide in toluene (86 mg solution, 0.58 mmol) under 
nitrogen. The mixture was stirred until complete as judged by TLC (ca. 3 h). The reaction mixture was 
evaporated and the residue was purified by column chromatography on Si60 in 
dichloromethane/methanol to yield a red-orange oil (62 %). TLC (DCM-methanol 20:1 v/v) Rf=0.43. 
IR (film): 2810, 2084, 1702, 1512, 1435, 1150, 1009, 909, 730 cm-1. 1H NMR (500 MHz, CDCl3) 
δ/ppm: 7.42 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 3.86 (s, 3H), 3.50 (s, 2H), 3.29 (d, J = 2.5 
Hz, 2H), 2.55 (d, J = 44.8 Hz, 8H), 2.24 (t, J = 2.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ/ppm: 
165.74, 136.03, 129.79, 124.04, 123.94, 78.94, 73.14, 62.45, 52.93, 52.02, 51.93, 46.83. HRMS (ESI) 
Calcd for C17H21N4O2+: (M + H)+, 313.1665; found: (M + H)+, 313.1659. 
 
tert-Butyl 4-(2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl)piperazine-1-carboxylate (45b). 1-
Boc-piperazine (0.362 g, 1.9 mmol) was dissolved in 15 ml of dry acetonitrile 
under nitrogen. K2CO3 (1.0 g, 7.0 mmol) was added, the mixture was heated up 
to reflux and compound 45a (prepared as previously described101) (0.5 g, 1.9 
mmol) as a solution in 5 ml of dry acetonitrile was introduced with continuous 
stirring. The mixture was refluxed for 18 h, then filtered and the filtrate evaporated under vacuum. The 
residue was purified by flash chromatography on Si60 in DCM/methanol to afford the target product 
as a colorless oil (0.551 g, 1.5 mmol, 80 %). TLC (DCM:methanol 20:1 v/v) Rf =0.14. 1H NMR (500.1 
MHz, CDCl3) , ppm: 3.68 (ddd, J = 4.5 Hz, J = 3.5 Hz, J = 2.0 Hz, 2H), 3.55-3.64 (m, 12H), 3.39-
3.41 (m, 4H), 2.55 (dd, J = 5.7 Hz, J = 5.7 Hz, 2H), 2.40-2.42 (m, 4H), 1.41 (s, 9H). 13C NMR (125.8 
MHz, CDCl3) , ppm: 154.69, 79.55, 72.70, 70.58, 70.24, 70.22, 68.64, 61.59, 57.85, 53.32, 43.96, 
42.93, 28.40. MS (ESI): Calcd for C17H34N2NaO6+ M+Na+ 385.2, found 385.3. 
 
tert-Butyl 4-(2-(2-(2-(2-(tosyloxy)ethoxy)ethoxy)ethoxy)ethyl)piperazine-1-carboxylate (45c). 
Compound 45b (0.550 g, 1.5 mmol) was mixed with triethylamine (0.307 g, 
3.0 mmol) and 4-dimethylaminopyridine (0.019 g, 0.16 mmol) in 30 ml of dry 
acetonitrile under nitrogen. p-Toluenesulfonyl chloride (0.318 g, 1.7 mmol) as 
a solution in 10 ml of dry acetonitrile was introduced at continuous stirring. 
The mixture was stirred at room temperature for 48 h, then evaporated under 
vacuum and residue was purified by flash chromatography on Si60 in 
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DCM/methanol to yield the target product as a colorless oil (0.517, 1.0 mmol, 66 %). TLC 
(DCM:methanol 20:1 v/v) Rf =0.28. 1H NMR (500.1 MHz, CDCl3) , ppm: 7.78 (d, J = 8.3 Hz, 2H), 
7.33 (d, J = 8.5 Hz, 2H), 4.14 (ddd, J = 4.5 Hz, J = 4.0 Hz, J = 3.0 Hz, 2H), 3.67 (ddd, J = 5.0 Hz, J = 
4.0 Hz, J = 3.5 Hz, 2H), 3.57-3.61 (m, 10H), 3.40-3.42 (m, 4H), 2.58 (dd, J = 6.0 Hz, J = 6.0 Hz, 2H), 
2.41-2.43 (m, 7H), 1.44 (s, 9H). 13C NMR (125.8 MHz, CDCl3) , ppm: 154.75, 144.81, 132.99, 
129.84, 127.99, 79.58, 70.77, 70.63, 70.52, 70.37, 69.23, 68.86, 68.70, 57.81, 53.37, 44.02, 43.00, 
28.43, 21.67. MS (ESI): Calcd for C24H41N2O8S+ M+H+ 517.3, found 517.2. 
 
tert-butyl 4-(2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)ethyl)piperazine-1-
carboxylate (45d). LiBr (0.695 g, 8.0 mmol) was mixed with dry acetone (12 
ml) and heated up to reflux under nitrogen.  Compound 45c (0.517 g, 1.0 
mmol) as a solution in 3 ml of dry acetone was added with continuous stirring 
and the mixture was refluxed until the reaction was complete as judged by TLC (2 h). The solution 
was then cooled to room temperature and evaporated under vacuum. The residue was mixed with 30 
ml of DCM and the white precipitate that formed was removed by filtration. The filtrate was taken up 
to dryness and the residue was purified by flash chromatography on Si60 in DCM/methanol to afford 
the target product as a colorless oil (0.419 g, 1.0 mmol, 98 %). TLC (DCM:methanol 20:1 v/v) Rf 
=0.28. 1H NMR (500.1 MHz, CDCl3) , ppm: 3.81 (dd, J = 6.3 Hz, J = 6.3 Hz, 2H), 3.61-3.69 (m, 
10H), 3.47 (dd, J = 6.3 Hz, J = 6.3 Hz, 2H), 3.42-3.44 (m, 4H), 2.60 (dd, J = 5.9 Hz, J = 5.9 Hz, 2H), 
2.43-2.45 (m, 4H), 1.45 (s, 9H). 13C NMR (125.8 MHz, CDCl3) , ppm: 154.77, 79.59, 71.23, 70.70, 
70.62, 70.58, 70.42, 68.91, 57.84, 53.38, 40.25, 30.31, 28.44. ESI MS: 425.2, 427.1 M+H+, 447.1, 
449.1 M+Na+. MS (ESI): Calcd for C17H34BrN2O5+ M+H+ 425.2, 427.2, found 425.2, 427.1; Calcd 
for C17H33BrN2NaO5+ M+Na+ 447.2, 449.2, found 447.1, 449.1. 
 
 
tert-Butyl 4-(2-(2-(2-(2-(piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)piperazine-1-carboxylate 
(45e).  Compound 45d (0.400 g, 0.93 mmol) was dissolved in 5 ml of dry 
acetonitrile and added to a stirring mixture of piperazine (0.404 g, 4.7 mmol) 
and K2CO3 (0.650 g, 4.7 mmol) in 15 ml of dry acetonitrile. The mixture was 
refluxed for 18 h under nitrogen. After cooling to room temperature the solids 
were filtered off, the filtrate was evaporated under vacuum and the residue was 
purified by flash chromatography on Si60 in DCM/methanol containing 0.5 % 
triethylamine. The final product was evaporated two times from toluene and dried under high vacuum 
to give a colorless oil (0.285 g, 0.66 mmol, 71 %). TLC (DCM:methanol 5:1 v/v containing 0.5 % 
Et3N) Rf =0.22. 1H NMR (500.1 MHz, CDCl3) , ppm: 3.56-3.62 (m, 12H), 3.39-3.41 (m, 4H), 2.87 
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(dd, J = 5.0 Hz, J = 5.0 Hz, 4H), 2.55 (ddd, J = 11.0 Hz, J = 5.5 Hz, J = 5.0 Hz, 4H), 2.38-2.46 (m, 
9H), 1.42 (s, 9H). 13C NMR (125.8 MHz, CDCl3) , ppm: 154.72, 79.55, 70.58, 70.39, 70.38, 68.69, 
68.82, 58.33, 57.81, 54.71, 53.36, 45.88, 44.00, 43.10. MS (ESI): Calcd for C21H43N4O5+ M+H+ 
431.3, found 431.3; Calcd for C21H42N4NaO5+ M+Na+ 453.3, found 453.2; Calcd for C21H42KN4O5+ 
M+K+ 469.3, found 469.2. 
 
Methyl 2-(4-((4-(2-(2-(2-(2-(4-(prop-2-yn-1-yl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)pi- 
perazin-1-yl)methyl)phenyl)acetate (45f). tert-Butyl 4-(2-(2-(2-(2-(piperazin-1-yl)ethoxy)- 
ethoxy)ethoxy)ethyl)piperazine-1-carboxylate 45e 
(0.10 g, 0.23 mmol) was mixed with K2CO3 (0.20 g) 
in dry acetonitrile (5 ml) under nitrogen. Methyl 4-
(bromomethyl)phenylacetate 36 (0.056 g, 0.23 mmol) as a solution in 5 ml of acetonitrile was added 
with continuous stirring. The mixture was stirred at room temperature until the reaction was complete 
as judged by TLC (2 h). The solids were then filtered off, the filtrate was evaporated to dryness under 
vacuum and the remaining colorless oil was dissolved in 5 ml of dry DCM. 2,6-Lutidine (0.093 g, 0.87 
mmol) was added and the mixture was cooled in an ice-water bath under nitrogen. TMSOTf (0.111 g, 
0.5 mmol) was introduced drop-wise with continuous stirring. The ice bath was removed and the 
mixture was stirred at ambient temperature until complete as judged by TLC (1 h). The solvent was 
removed under vacuum and the remaining oil was dissolved in dry acetonitrile (5 ml), K2CO3 (0.26 g) 
was added and the mixture was stirred for 10 min under nitrogen. Propargyl bromide (0.056 g, 0.36 
mmol) as a solution in toluene was then added and the mixture was stirred at room temperature until 
complete as judged by TLC (1 h). The solvent was taken up to dryness under vacuum and the residue 
was purified by flash chromatography on Si60 in DCM/methanol to afford the desired product as a 
colorless oil (0.098 g, 0.18 mmol, 80 %). TLC (DCM:methanol 10:1 v/v) Rf=0.10. 1H NMR (500.1 
MHz, CD3CN) , ppm: 7.27 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 8.2 Hz, 2H), 4.53 (br s, 1H), 3.63 (s, 3H), 
3.53-3.62 (m, 16H), 3.27 (d, J = 2.5 Hz, 2H), 2.50-2.76 (m, 21 H). 13C NMR (125.8 MHz, CD3CN) , 
ppm: 172.89, 137.38, 134.53, 130.23, 130.08, 79.79, 74.39, 70.78, 70.74, 70.69, 68.15, 67.59, 62.47, 
58.08, 57.89, 53.96, 53.89, 52.53, 52.38, 51.63, 46.88, 40.90. MS (ESI): Calcd for C29H47N4O5+ 
M+H+ 531.4, found 531.3; Calcd for C29H46N4NaO5+ M+Na+ 553.3, found 553.3; Calcd for 
C29H46KN4O5+ M+K+ 569.3, found 569.3. 
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Methyl 2-diazo-2-(4-((4-(2-(2-(2-(2-(4-(prop-2-yn-1-yl)piperazin-1-yl)ethoxy)ethoxy)ethoxy) 
ethyl)piperazin-1-yl)methyl)phenyl)acetate (45, Dz5). Compound 45f (0.090 g, 0.17 mmol) was 
mixed with p-acetamidobenzensulfonyl azide (0.062 
g, 0.26 mmol) in 5 ml of dry acetonitrile under 
nitrogen. DBU (0.103 g, 0.68 mmol) was introduced 
drop-wise with continuous stirring. The mixture was stirred for 48 h at room temperature, then 
evaporated to dryness under vacuum. Purification of the residue by flash chromatography on Si60 in 
DCM/methanol yielded the target product as an orange-yellow oil (0.028 g, 0.05 mmol, 30 %). TLC 
(DCM:methanol 10:1 v/v) Rf=0.22. 1H NMR (500.1 MHz, CD3CN) , ppm: 7.44 (d, J = 8.5 Hz, 2H), 
7.33 (d, J = 8.5 Hz, 2H), 3.81 (s, 3H), 3.49-3.54 (m, 12H), 3.44 (s, 2H), 3.22 (d, J = 2.5 Hz, 2H), 2.39-
2.49 (m, 21H). 13C NMR (125.8 MHz, CD3CN) , ppm: 166.48, 137.53, 130.49, 125.19, 124.83, 
80.19, 74.15, 71.11, 71.01, 69.53, 69.47, 62.90, 58.57, 58.51, 54.42, 54.24, 53.92, 52.61, 52.52, 47.12. 
MS (ESI): Calcd for C29H45N6O5+ M+H+ 557.3, found 557.4; Calcd for C29H44N6NaO5+ M+Na+ 
579.3, found 579.3; Calcd for C29H44KN6O5+ M+K+ 595.3, found 595.3. 
 
Rhodamine B 2,3,4,5,6-pentafluorophenyl ester (46a). Rhodamine B 
(0.600 g, 1.35 mmol), 2,3,4,5,6-pentafluorophenol (0.250 g, 1.36 mmol) 
and 4-(N,N-dimethylamino)pyridine (0.021 g, 0.17 mmol) were 
dissolved in 20 ml of dry DCM under nitrogen and N,N’-
dicyclohexylcarbodiimide (0.327 g, 1.59 mmol) as a solution in 2 ml of 
DCM was added with continuous stirring. The mixture was stirred at 
room temperature until complete as judged by TLC (1.5 h). It was then evaporated and the residue 
purified by column chromatography on Si60 in DCM/methanol to afford the target product as a deep-
purple solid (0.610 g, 1.0 mmol, 74 %). TLC (DCM:methanol 10:1 v/v) Rf=0.20. 1H NMR (500.1 
MHz, CD3CN) , ppm: 8.53 (dd, J = 8.0 Hz, J = 1.0 Hz, 1H), 8.02 (ddd, J = 7.6 Hz, J = 7.6 Hz, J = 1.3 
Hz, 1H), 7.93 (ddd, J = 7.8 Hz, J = 7.8 Hz, J = 1.3 Hz, 1H), 7.53 (dd, J = 7.6 Hz, J = 1.0 Hz, 1H), 7.12 
(d, J = 9.5 Hz, 2H), 6.98 (dd, J = 9.6 Hz, J = 2.5 Hz, 2H), 6.82 (d, J = 2.5 Hz, 2H), 3.62 (q, J = 7.2 Hz, 
8H), 1.23 (t, J = 7.1 Hz, 12H). 13C NMR (125.8 MHz, CD3CN) , ppm: 162.47, 158.67, 157.44, 
156.63, 142.91 (m, CF), 140.91 (m, CF), 139.88 (m, CF), 137.93 (m, CF), 135.96, 135.79, 133.05, 
131.90, 131.82, 131.77, 127.45, 115.47, 114.14, 96.95, 46.66, 12.72.  19F NMR (376.5 MHz, CD3CN) 
, ppm: -154.76 (d, J = 16.8 Hz), -159.47 (t, J = 21.0 Hz), -164.16 (dd, J = 16.9 Hz, J = 21.9 Hz). MS 
(ESI): Calcd for C34H30F5N2O3+ M+ 609.2, found 609.3. 
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1-(2-Azidoacetyl)-4-rhodamine B piperazine (46). Compound 46a (0.035 g, 0.06 mmol) was 
dissolved in 5 ml of dry acetonitrile and N-(2-
azidoacetyl)piperazine102 (0.014 g, 0.08 mmol) as a solution in 1 ml 
of acetonitrile was added with continuous stirring under nitrogen. 
The mixture was stirred for 24 h at room temperature, then 
evaporated under vacuum and the residue purified by column 
chromatography on Si60 in DCM/methanol to afford a deep purplish-violet waxy solid (0.016 g, 0.03 
mmol, 48 %). TLC (DCM:methanol 5:1 v/v) Rf=0.32. 1H NMR (500.1 MHz, DMSO-d6) , ppm: 7.71-
7.78 (m, 3H), 7.52-7.53 (m, 1H), 7.10-7.16 (m, 4H), 6.95 (d, J = 2.3 Hz), 4.11-4.13 (m, 3H), 3.66 (q, J 
= 7.2 Hz, 8H), 3.39-3.41 (m, 3H), 3.22-3.24 (m, 1H), 2.65-2.69 (m, 3H), 1.20 (t, J = 7.2 Hz, 12H). 13C 
NMR (125.8 MHz, DMSO-d6) , ppm: 166.07, 165.77, 157.05, 155.54, 155.11, 135.13, 131.77, 
130.82, 130.74, 130.71, 130.45, 129.82, 127.54, 114.30, 113.02, 95.90, 49.67, 45.40, 45.36, 45.15, 
45.08, 42.31, 12.47. MS (ESI): Calcd for C34H40N7O3+ M+ 594.3, found 594.4. 
 
1-(2-Azidoacetyl)-4-(D-biotinyl)piperazine (47). D-Biotin 4-nitrophenyl ester (0.068 g, 0.19 mmol) 
was suspended in 5 ml of dry acetonitrile and N-(2-
azidoacetyl)piperazine102 (0.042 g, 0.25 mmol) as a solution in 1 ml 
of acetonitrile was added with continuous stirring under nitrogen. 
The mixture was stirred for 24 h at room temperature, then 
evaporated under vacuum and the residue purified by column chromatography on Si60 in 
DCM/methanol to afford a colorless oil which was crystallized from chloroform (0.062 g, 0.16 mmol, 
84 %). TLC (DCM:methanol 10:1 v/v) Rf=0.23. 1H NMR (500.1 MHz, CD3CN) , ppm: 5.42 (br s, 
1H), 5.15 (br s, 1H), 4.41 (dddd, J = 6.5 Hz, J = 5.0 Hz, J = 2.5 Hz, J = 1.0 Hz, 1H), 4.24 (ddd, J = 8.0 
Hz, J = 4.5 Hz, J = 2.0 Hz, 1H), 3.99 (s, 2H), 3.47-3.56 (m, 6H), 3.28-3.34 (m, 2H), 3.17 (ddd, J = 7.9 
Hz, J = 6.9 Hz, J = 4.5 Hz, 1H), 2.88 (dd, J = 12.7 Hz, J = 5.0 Hz, 1H), 2.63 (d, J = 12.7 Hz, 1H), 2.35 
(dd, J = 8.1 Hz, J = 7.0 Hz, 2H), 1.65-1.72 (m, 1H), 1.53-1.63 (m, 3H), 1.38-1.44 (m, 2H). 13C NMR 
(125.8 MHz, CD3CN) , ppm: 172.37, 167.13, 163.83, 62.30, 60.71, 56.30, 50.99, 45.75, 45.40, 45.11, 
42.63, 42.32, 41.74, 41.66, 41.12, 33.19, 29.10, 29.04, 25.75. ESI MS: 418.2 M+Na+. ESI MS: Calcd 
for C16H25N7NaO3S+ M+Na+ 418.2, found 418.2. 
 
5.3.1. Monoalkylation of small anilines with copper(I) carbenoids derived from Dz1 in aqueous 
media 
Compound 37 (Dz1, 0.082 mmol) and the respective aniline or aminopyridine (0.090 mmol) were 
mixed in tert-butanol (0.33 ml) under nitrogen, 500 mM MES buffer, pH 6.0 (0.65 ml), 50 mM CuSO4 
in water (0.016 ml) and water (0.47 ml) were then added, the mixture was stirred, and 200 mM sodium 
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ascorbate in water (0.16 ml) was introduced. The mixture was stirred for 1 h (compounds 3a-g) or 
overnight (compounds 3h and 3i) at room temperature. Equal volume of 10 % (w/v) K2CO3 was 
added, and the mixture was extracted with 3× 4 ml of dichloromethane. The combined organic layers 
were dried with anhydrous sodium sulfate, evaporated to dryness under vacuum and the residue 
purified by column chromatography on Si60 in DCM/methanol to yield the desired product.  
 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-(phenylamino) acetate (53a). Light yellow oil (85 
%). TLC (DCM-methanol 20:1 v/v) Rf=0.38. IR (film) 2768, 1735, 1601, 
1504, 1432, 1309, 1253, 1170, 1018, 857, 746, 691, 508 cm-1. 1H NMR (500 
MHz, CDCl3) δ/ppm: 7.45 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.12 
(dd, J = 8.5, 7.4 Hz, 2H), 6.70 (dd, J = 7.3, 7.3 Hz, 1H), 6.56 (d, J = 7.7 Hz, 
2H), 5.07 (d, J = 6.0 Hz, 1H), 4.93 (d, J = 5.8 Hz, 1H), 3.73 (s, 3H), 3.44 (s, 2H), 2.26 (s, 6H). 13C 
NMR (126 MHz, CDCl3) δ/ppm: 172.49, 146.07, 138.71, 136.65, 129.80, 129.36, 127.35, 118.23, 
113.50, 63.93, 60.62, 52.93, 45.39. HRMS (ESI) Calcd. for C18H23N2O+: (M + H)+, 299.1760; found: 
(M + H)+, 299.1754. 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-(methyl(phenyl)amino) acetate (53b). 
Colorless oil (82 %). TLC (DCM-methanol 20:1 v/v) Rf=0.33. IR (film) 
2767, 1742, 1570, 1503, 1169, 1106, 1002, 749, 691 cm-1. 1H NMR (400 
MHz, CDCl3) δ/ppm: 7.30 (d, J = 8.2 Hz, 2H), 7.27 – 7.18 (m, 4H), 6.84 (d, J 
= 8.0 Hz, 2H), 6.80 – 6.74 (m, 1H), 5.62 (s, 1H), 3.75 (s, 3H), 3.44 (s, 2H), 
2.75 (s, 3H), 2.25 (s, 6H). 13C NMR (101 MHz, CDCl3) δ/ppm: 172.41, 149.85, 138.34, 134.78, 
129.47, 129.31, 128.43, 118.08, 113.45, 65.48, 63.78, 52.02, 45.26, 34.46. HRMS (ESI) Calcd. for 
C19H25N2O2+: (M + H)+, 313.1916; found: (M + H)+, 313.1914. 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-((4-methoxyphenyl)amino) acetate (53c). 
Colorless oil (75 %). TLC (DCM-methanol 20:1 v/v) Rf=0.35. IR (film) 
1735, 1510, 1235, 1033, 818 cm-1 1H NMR (500 MHz, CDCl3) δ/ppm: 7.44 
(d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.72 (d, J = 8.9 Hz, 2H), 6.53 (d, 
J = 8.9 Hz, 2H), 5.01 (d, J = 6.4 Hz, 1H), 4.64 (d, J = 6.4 Hz, 1H), 3.72 (s, 
3H), 3.70 (s, 3H), 3.44 (s, 2H), 2.26 (s, 6H).  13C NMR (126 MHz, CDCl3) δ/ppm: 172.61, 152.52, 
140.21, 138.41, 136.75, 129.68, 127.27, 114.84, 114.77, 63.80, 61.43, 55.69, 52.74, 45.25. HRMS 
(ESI) Calcd. for C19H25N2O3+: (M + H)+, 329.1865; found: (M + H)+, 329.1865.  
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Methyl 2-((4-chlorophenyl)amino)-2-(4-((dimethylamino)methyl)phenyl) acetate (53d). 
Colorless oil (77 %). TLC (DCM-methanol 20:1 v/v) Rf=0.35. IR (film) 
1735, 1598, 1498, 1312, 1171, 1018, 815 cm-1 1H NMR (500 MHz, CDCl3) 
δ/ppm: 7.42 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 7.05 (d, J = 8.9 Hz, 
2H), 6.46 (d, J = 8.9 Hz, 2H), 5.02 (d, J = 6.0 Hz, 1H), 4.97 (d, J = 5.9 Hz, 
1H), 3.73 (s, 3H), 3.44 (s, 2H), 2.26 (s, 6H). 13C NMR (126 MHz, CDCl3) δ/ppm: 172.08, 144.44, 
138.73, 136.06, 129.75, 129.09, 127.19, 122.75, 114.50, 63.78, 60.46, 52.92, 45.28. HRMS (ESI) 
Calcd. for C18H22ClN2O2+: (M + H)+, 333.1370; found: (M + H)+, 333.1363. 
 
Ethyl 4-((1-(4-((dimethylamino)methyl)phenyl)-2-methoxy-2-oxoethyl)amino) benzoate 
(53e). Colorless oil (70 %). TLC (DCM-methanol 20:1 v/v) Rf=0.33. IR 
(film) 1737, 1697, 1603, 1523, 1265, 1169, 1098, 1018, 839, 769, 698 cm-1. 
1H NMR (500 MHz, CDCl3) δ/ppm: 7.81 (d, J = 8.8 Hz, 2H), 7.42 (d, J = 8.1 
Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 6.51 (d, J = 8.9 Hz, 2H), 5.41 (d, J = 5.8 
Hz, 1H), 5.12 (d, J = 5.8 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.74 (s, 3H), 3.43 
(s, 2H), 2.25 (s, 6H), 1.32 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ/ppm: 171.74, 166.67, 
149.43, 138.90, 135.70, 131.41, 129.79, 127.15, 119.70, 112.32, 77.30, 77.05, 76.79, 63.75, 60.25, 
59.81, 53.04, 45.28, 14.42. HRMS (ESI) Calcd. for C21H27N2O4+: (M + H)+, 371.1971; found: (M + 
H)+, 371.1971. 
 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-((4-(trifluoromethyl)phenyl)amino)acetate 
(53f). Colorless oil (74 %). TLC (DCM-methanol 20:1 v/v) Rf=0.30. IR 
(film) 1737, 1616, 1532, 1315, 1105, 1064, 825 cm-1. 1H NMR (500 
MHz, CDCl3) δ/ppm: 7.42 (d, J = 8.1 Hz, 2H), 7.35-7.32 (m, 4H), 6.55 
(d, J = 8.5 Hz, 2H), 5.33 (d, J = 5.7 Hz, 1H), 5.08 (d, J = 5.7 Hz, 1H), 
3.75 (s, 3H), 3.44 (s, 2H), 2.26 (s, 6H). 13C NMR (126 MHz, CDCl3) δ/ppm: 13C NMR (126 
MHz, CDCl3) δ/ppm: 171.74, 148.21, 138.83, 135.65, 129.79, 127.11, 126.57 (q, J=4 Hz), 
124.76 (q, J=271 Hz), 119.61 (q, J=33 Hz), 112.58, 63.71, 59.88, 53.02, 45.24. HRMS (ESI) 
Calcd. for C19H22F3N2O2
+: (M + H)+, 367.1633; found: (M + H)+, 367.1633. 
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Methyl 2-((4-acetylphenyl)amino)-2-(4-((dimethylamino)methyl)phenyl) acetate (53g). 
Colorless oil (75 %). TLC (DCM-methanol 20:1 v/v) Rf=0.30. IR (film) 
2769, 1737, 1660,1594, 1524, 1420, 1357, 1270, 1171, 1018, 825, 591cm-1 
1H NMR (500 MHz, CDCl3) δ/ppm: 7.75 (d, J = 8.8 Hz, 2H), 7.41 (d, J = 8.1 
Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 6.52 (d, J = 8.9 Hz, 2H), 5.51 (d, J = 5.7 
Hz, 1H), 5.13 (d, J = 5.8 Hz, 1H), 3.75 (s, 3H), 3.43 (s, 2H), 2.45 (s, 3H), 
2.25 (s, 6H). 13C NMR (126 MHz, CDCl3) δ/ppm: 196.38, 171.63, 149.68, 139.01, 135.57, 130.65, 
129.83, 127.52, 127.13, 112.32, 63.75, 59.72, 53.10, 45.28, 26.05. HRMS (ESI) Calcd. for 
C20H25N2O3+: (M + H)+, 341.1865; found: (M + H)+, 341.1863. 
 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-(pyridin-2-ylamino) acetate (53h). 
Colorless oil (51 %). TLC (DCM-methanol 20:1 v/v) Rf=0.25. IR (film) 
2768, 1737, 1600, 1480, 1169, 1018, 772 cm-1. 1H NMR (500 MHz, CD3CN) 
δ/ppm: 7.98 (dd, J = 5.6, 1.9 Hz, 1H), 7.41 (d, J = 8.0 Hz, 3H), 7.32 (d, J = 
8.3 Hz, 2H), 6.71 – 6.53 (m, 2H), 5.88 (s, 1H), 5.55 (d, J = 7.0 Hz, 1H), 3.64 
(s, 3H), 3.41 (s, 2H), 2.17 (s, 6H). 13C NMR (126 MHz, CD3CN) δ/ppm: 172.70, 157.46, 147.45, 
139.46, 137.11, 136.27, 129.35, 127.57, 113.45, 109.04, 63.20, 58.26, 51.91, 44.48. HRMS (ESI) 
Calcd. for C17H22N3O2+: (M + H)+, 300.1712; found: (M + H)+, 300.1706. 
 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-(pyridin-3-ylamino) acetate (53i). Yellow 
oil (76 %). TLC (DCM-methanol 20:1 v/v) Rf=0.0.23. IR (film) 2769, 1737, 
1587, 1480, 1171, 1017, 795, 708 cm-1. 1H NMR (500 MHz, CD3CN) δ/ppm:  
8.06 (s, 1H), 7.89 (s, 1H), 7.44 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H), 
7.05 (s, 1H), 6.92 (d, J = 6.6 Hz, 1H), 5.48 (d, J = 7.1 Hz, 1H), 5.20 (d, J = 
7.3 Hz, 1H), 3.67 (s, 3H), 3.44 (s, 2H), 2.19 (s, 6H). 13C NMR (126 MHz, CD3CN) δ/ppm: 171.86, 
139.08, 138.83, 136.26, 136.22, 129.57, 127.36, 123.71, 119.20, 62.95, 59.48, 52.36, 44.31. HRMS 
(ESI) Calcd. for C17H22N3O2+: (M + H)+, 300.1712; found: (M + H)+, 300.1709. 
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Figure E1│UPLC trace of the Cu(I)-catalyzed alkylation reaction of a series of p-substituted anilines with Dz1 
(Sections A-F correspond to entries 1 and 3-7 in Table 7). The singly (S) and doubly alkylated (D) anilines were 
identified by ESI-MS  
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Figure E2│UPLC trace of the Cu(I)-catalyzed alkylation reaction of a series of 2- and 3-
aminopyridine with Dz1 (Sections A and B correspond to entries 8 and 9 in Table 7). The singly (S) 
and doubly alkylated (D) anilines were identified by ESI-MS. 
 
 
5.3.2. Auto-catalytic tandem CuAAC/N-H insertion with small anilines 
Methyl 2-(4-((dimethylamino)methyl)phenyl)-2-((4-(1-(3-hydroxypropyl)-1H-1,2,3-triazol-4-
yl)phenyl)amino) acetate (55). Compound 37 (Dz1, 0.064 mmol), 4-ethynylaniline (0.071 mmol) and 
3-azidopropan-1-ol86 (0.077 mmol) were mixed in tert-butanol (0.45 ml) 
under nitrogen, and 500 mM MES buffer, pH 6.0 (0.514 ml), 50 mM 
CuSO4 in water (0.013 ml) and water (0.245 ml) were then added, the 
mixture was stirred, and 400 mM sodium ascorbate in water (0.064 ml) 
was introduced. The mixture was stirred for overnight at room temperature. Then an equal volume of 
10 % (w/v) K2CO3 was added, and the mixture was extracted with 3× 3 ml of dichloromethane. The 
combined organic layers were dried with anhydrous sodium sulfate, evaporated under vacuum and the 
residue purified by column chromatography on Si60 in dichloromethane/methanol to yield the desired 
product as a colorless oil (62 %). TLC (DCM-methanol 20:1 v/v) Rf=0.10. IR (film) 2948, 1735, 1617, 
1564, 1502, 1456, 1317, 1172, 1041, 798 cm-1. 1H NMR (500 MHz, MeOD) δ/ppm: 8.09 (s, 1H), 7.59 
– 7.46 (m, 4H), 7.34 (d, J = 8.2 Hz, 2H), 6.70 (d, J = 8.8 Hz, 2H), 5.23 (s, 1H), 4.50 (t, J = 7.0 Hz, 
2H), 3.71 (s, 3H), 3.58 (t, J = 6.1 Hz, 2H), 3.55 (s, 2H), 2.29 (s, 6H), 2.17 – 2.08 (m, 2H). 13C NMR 
(126 MHz, MeOD) δ/ppm: 173.80, 149.32, 148.29, 138.70, 138.13, 131.23, 128.77, 127.63, 121.07, 
120.92, 114.75, 64.22, 61.50, 59.31, 53.05, 48.26, 45.00, 33.99. HRMS (ESI) Calcd. for C23H30N5O3+: 
(M + H)+, 424.2349; found: (M + H)+, 424.2343. 
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Methyl 2-(4-((4-((1-(2-oxo-2-(4-(5-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentano-
yl)piperazin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)methyl)phenyl)-2-(phenyl- 
amino) acetate (56). Compound 44 (Dz4, 0.058 mmol) and aniline (0.063 mmol) were mixed in tert-
butanol (0.406 ml) under nitrogen, and 500 mM MES buffer, pH 6.0 
(0.464 ml), 50 mM CuSO4 in water (0.012 ml) and 1-(2-azidoacetyl)-4-
(D-biotinyl)piperazine 47 (0.069 mmol) dissolved in water (0.220 ml) 
were then added, the mixture was stirred, and 400 mM sodium 
ascorbate in water (0.058 ml) was introduced. The mixture was stirred 
for overnight at room temperature. Then an equal volume of 10 % 
(w/v) K2CO3 was added, and the mixture was extracted with 3× 3 ml of 
dichloromethane. The combined organic layers were dried with 
anhydrous sodium sulfate, evaporated under vacuum and the residue 
purified by column chromatography on Si60 in dichloromethane/methanol to yield the desired product 
as a colorless oil (70 %). TLC (DCM-methanol 4:1 v/v) Rf=0.25. IR (film) 1665, 1500, 1421, 1215, 
1006, 825, 751, 693 cm-1. 1H NMR (500 MHz, MeOD) δ/ppm: 7.89 (s, 1H), 7.48 (d, J = 8.1 Hz, 2H), 
7.33 (d, J = 8.2 Hz, 2H), 7.07 (dd, J = 8.5, 7.5 Hz, 2H), 6.66-6.62 (m, 3H), 5.51 (s, 2H), 5.16 (s, 1H), 
4.56 – 4.45 (m, 1H), 4.32 (dd, J = 7.7, 4.5 Hz, 1H), 3.77 – 3.58 (m, 13H), 3.54 (s, 2H), 3.22 (dd, J = 
7.9, 5.5 Hz, 1H), 2.94 (dd, J = 12.8, 4.9 Hz, 1H), 2.79 – 2.41 (m, 10H), 1.84 – 1.58 (m, 4H), 1.55 – 
1.45 (m, 2H). 13C NMR (126 MHz, MeOD) δ/ppm: 172.73, 165.13, 165.04, 164.70, 146.65, 142.85, 
137.03, 136.96, 129.66, 128.61, 127.19, 125.95, 117.48, 113.27, 61.95, 61.88, 60.32, 60.23, 55.63, 
52.11, 51.90, 51.58, 50.61, 48.45, 45.00, 44.79, 44.62, 44.27, 41.99, 41.60, 41.10, 40.85, 39.66, 32.23, 
32.18, 28.48, 28.15, 24.84. HRMS (ESI) Calcd. for C39H53N10O5S+: (M + H)+, 773.3921; found: (M + 
H)+, 773.3921. 
 
Prop-2-yn-1-yl 2-diazo-2-(4-((dimethylamino)methyl)phenyl) acetate (57, Dz8). 4-(Bromomethyl)- 
phenylacetic acid 35 (0.117 g, 0.51 mmol) was mixed with propargyl 
alcohol (0.084 g, 1.5 mmol) and 1,2-dichloroethane (0.5 ml) were mixed 
in a 4-ml screw top vial with a teflon cap. A drop of concentrated 
sulfuric acid was added and the vial was closed tightly and heated at 
80°C for 1h. The mixture was then diluted with 3 ml of dichloromethane, washed with 2 × 4 ml of 
saturated sodium bicarbonate, dried with anhydrous sodium sulfate and evaporated to dryness under 
vacuum. The residue was passed through a small pad of Si60 in dichloromethane/methanol 100:1 and 
the first fraction was evaporated and dried under high vacuum. The residue was mixed with ethanol (2 
ml) and 4 ml of 5.6 M dimethylamine in ethanol were added. The mixture was kept for 1 h at room 
temperature, then taken up to dryness, re-dissolved in 5 ml of dichloromethane, washed with 2 × 5 ml 
of saturated sodium carbonate solution, then dried with anhydrous sodium sulfate, taken up to dryness 
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and dried under high vacuum. The residue was dissolved in dry acetontrile (5 ml) under nitrogen, and 
p-acetamidobenzenesulfonyl azide (0.135 g, 0.56 mmol) and DBU (0.154 g, 1.0 mmol) were then 
added, and the mixture was stirred for 24 h at room temperature. The mixture was then evaporated 
under vacuum and the residue purified by flash chromatography on Si60 in dichloromethane/methanol 
to afford a yellow-orange oil (55 %). TLC (DCM-methanol 4:1 v/v) Rf=0.25. IR (film) 2768, 2084, 
1701, 1513, 1336, 1240, 1144, 1036, 808 cm-1. 1H NMR (500 MHz, CD3CN) δ/ppm: 7.44 (d, J = 8.5 
Hz, 2H), 7.34 (d, J = 8.7 Hz, 2H), 4.86 (d, J = 2.5 Hz, 2H), 3.38 (s, 2H), 2.82 (t, J = 2.5 Hz, 1H), 2.16 
(s, 6H). 13C NMR (126 MHz, CD3CN) δ/ppm: 164.33, 137.60, 129.49, 123.96, 123.75, 77.93, 75.51, 
63.19, 52.12, 44.53. HRMS (ESI) Calcd. for C17H22N3O2+: (M + H)+, 258.1243; found: (M + H)+, 
258.1237. 
 
5.3.3. Direct alkylation of 2′-deoxynucleoside-5′-monophosphates 
Typically 2′-deoxyadenosine-5′-monophosphate or 2′-deoxycytidine-5′-monophosphate sodium salt 
(0.1-0.2 mmol) was suspended in DMSO (0.5 ml) under argon and the respective alkyl bromide or 
iodide (2-5 eq) was added drop-wise at continuous stirring. The mixture was stirred at room 
temperature. The reaction progress was checked by diluting small aliquots with 100 mM 
triethylammonium acetate buffer, pH 7.1/acetonitrile 1:1 and injecting into ESI MS. The mixture was 
then precipitated with 40-80 volumes of acetone at room temperature, the precipitate was recovered by 
centrifugation and washed twice by resuspension in acetone and centrifugation. It was then dried 
under high vacuum and purified by preparative RP-HPLC in water/acetonitrile. The appropriate 
fractions were combined and freeze-dried to afford the desired alkylated products as white solids. 
The alkylation of the nucleobase was confirmed by ESI tandem MS of the target product, where the 
mass for the alkylated nucleobase was found in all cases. For compound 61c only the cation of the 
singly-alkylated base was observed. This together with the splitting pattern of the propargyl CH2-
protons due to spin-spin coupling to the 5′-phosphoros suggests the second alkylation took place on 
the phosphate.  
 
N1-(n-Butyl)-2′-deoxyadenosine-5′-monophosphate (60c). The reaction was done with 1.1 mmol 
nucleoside derivative and 5 eq 1-iodobutane, reaction time 3 days. 
The purification was carried out by semi-preparative HPLC in 100 
mM triethylammonium acetate buffer, pH 7.1/acetonitrile. The final 
product was re-dissolved in water and freeze-dried three times to 
remove the triethylammonium acetate, however, some residual 
amount was still present. Yield 2 mg (0.005 mmol, 4.5 %). 1H NMR (500 MHz, D2O) δ/ppm: 8.63 (s, 
1H), 8.52 (s, 1H), 6.55 (t, J = 6.7 Hz, 1H), 4.77 – 4.71 (m, 1H), 4.32 (t, J = 7.5 Hz, 2H), 4.29-4.27 (m, 
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1H), 4.02 (dd, J = 5.0, 3.6 Hz, 2H), 2.87 (ddd, J = 14.0, 6.9, 6.1 Hz, 1H), 2.61 (ddd, J = 14.1, 6.5, 3.7 
Hz, 1H), 1.88-1.82 (m, 2H), 1.43-1.36 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). MS (ESI) Calcd. for 
C14H23N5O6P+: M+, 388.1; found: 388.3. 
N1-Allyl-2′-deoxyadenosine-5′-monophosphate (60d). The reaction was done with 2 mmol 
nucleoside derivative and 4 eq allyl bromide, reaction time 20 h. 
Yield 7 mg (0.02 mmol, 9 %). 1H NMR (600 MHz, D2O) δ/ppm: 8.63 
(s, 1H), 8.55 (s, 1H), 6.59 (t, J = 6.7 Hz, 1H), 6.12-6.06 (m, 1H), 5.46-
5.43 (m, 1H), 5.21-5.18 (m, 1H), 5.00-4.99 (m, 2H), 4.78-4.76 (m, 
1H), 4.33-4.31 (m, 1H), 4.09-4.08 (m, 1H), 2.93-2.88 (m, 1H), 2.68-2.64 (m, 1H). 13C NMR (151 
MHz, D2O) δ/ppm: 150.26, 147.37, 146.82, 143.06, 128.43, 119.26, 119.07, 86.39, 86.33, 84.75, 
71.17, 64.56, 64.53, 52.29, 39.26. 31P1H (202 MHz, D2O) δ/ppm: 0.24. MS (ESI) Calcd. for 
C13H19N5O6P+: M+, 372.1; found:372.2. 
N1-(trans-2-hexenyl)-2′-deoxyadenosine-5′-monophosphate (60e). The reaction was done with 1.4 
mmol nucleoside derivative and 3 eq trans-2-hexenyl bromide, 
reaction time 48 h. Yield 8 mg (0.02 mmol, 14 %). 1H NMR 
(500 MHz, D2O) δ/ppm: 8.59 (s, 1H), 8.52 (s, 1H), 6.55 (t, J = 
6.7 Hz, 1H), 5.80-5.74 (m, 1H), 5.70-5.64 (m, 1H), 4.89-4.87 (m, 
2H), 4.75-4.72 (m, 1H), 4.30-4.27 (m, 1H), 4.05 (dd, J = 5.2, 3.6 
Hz, 2H), 2.86 (ddd, J = 14.1, 6.9, 6.1 Hz, 1H), 2.62 (ddd, J = 14.1, 6.5, 3.7 Hz, 1H), 2.05 (qd, J = 7.0, 
1.2 Hz, 2H), 1.39-1.32 (m, 2H), 0.82 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, D2O) δ/ppm: 150.11, 
147.16, 146.76, 142.94, 137.67, 119.68, 119.15, 86.32, 86.25, 84.64, 71.14, 64.56, 64.52, 52.08, 
39.23, 33.56, 21.20, 12.73. 31P1H (202 MHz, D2O) δ/ppm: 0.14. MS (ESI) Calcd. for C16H25N5O6P+: 
M+, 414.2; found: 414.3. 
N1-(cis-2-hexenyl)-2′-deoxyadenosine-5′-monophosphate (60f). The reaction was done with 1.4 
mmol nucleoside derivative and 4 eq cis-2-hexenyl bromide, 
reaction time 48 h. Yield 10 mg (0.024 mmol, 16 %). 1H NMR (500 
MHz, D2O) δ/ppm: 8.58 (s, 1H), 8.52 (s, 1H), 6.54 (t, J = 6.7 Hz, 
1H), 6.00-5.95 (m, 1H), 5.66-5.61 (m, 1H), 4.96-4.95 (m, 2H), 
4.74-4.72 (m, 1H), 4.30-4.27 (m, 1H), 4.06-4.04 (m, 2H), 2.86 (ddd, 
J = 14.1, 6.9, 6.1 Hz, 1H), 2.62 (ddd, J = 14.1, 6.6, 3.8 Hz, 1H), 2.28-2.13 (m, 2H), 1.47-1.39 (m, 2H), 
0.89 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, D2O) δ/ppm: 150.36, 146.72, 146.68, 142.98, 139.14, 
119.20, 118.64, 86.32, 86.25, 84.66, 71.13, 64.57, 64.53, 47.75, 39.22, 29.10, 21.69, 12.90. 31P1H 
(202 MHz, D2O) δ/ppm: 0.13. MS (ESI) Calcd. for C16H25N5O6P+: M+, 414.2; found: 414.3. 
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N3-(cis-2-hexenyl)-2′-deoxycytidine-5′-monophosphate (61a). The reaction was done with 1.4 mmol 
nucleoside derivative and 2 eq cis-2-hexenyl bromide, reaction time 1 h. 
Yield 2 mg (0.005 mmol, 3 %). 1H NMR (500 MHz, D2O) δ/ppm: 8.19 
(d, J = 8.0 Hz, 1H), 6.32 (d, J = 8.0 Hz, 1H), 6.23 (t, J = 6.3 Hz), 5.84-
5.78 (m, 1H), 5.40-5.35 (m, 1H), 4.72-4.71 (m, 2H), 4.55-4.52 (m, 1H), 
4.25-4.23 (m, 1H), 4.11 (ddd, J = 11.7, 4.3, 2.8 Hz), 4.03 (ddd, J = 11.7, 
5.1, 3.0 Hz, 1H), 2.50 (ddd, J = 14.2, 6.3, 3.9 Hz, 1H), 2.36-2.31 (m, 1H), 2.19-2.14 (m, 2H), 1.45-
1.38 (m, 2H), 0.90 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, D2O) δ/ppm 158.96, 148.31, 141.90, 
137.25, 118.75, 95.37, 87.79, 86.45, 70.54, 64.06, 41.72, 39.80, 29.16, 21.87, 12.99. 31P1H (202 
MHz, D2O) δ/ppm: 0.38. MS (ESI) Calcd. for C15H25N3O7P+: M+, 390.1; found: 390.2. 
Propargylation of 2′-deoxycytidine-5′-monophosphate. The nucleoside derivative (1.5 mmol) was 
alkylated with 2.5 eq of propargyl bromide (as 80 % w/w solution in toluene) for 20 h at room 
temperature. Compounds 61b and 61c were isolated as the major products of the reaction.  
N3-(propargyl)-2′-deoxycytidine-5′-monophosphate (61b). Yield 5 mg (0.014 mmol, 9 %). 1H 
NMR (500 MHz, D2O) δ/ppm: 8.18 (d, J = 8.0 Hz, 1H), 6.34 (d, J = 8.0 
Hz, 1H), 6.25 (t, J = 6.3 Hz, 1H), 4.87 (t, J = 2.5 Hz, 2H), 4.55-4.53 (m, 
1H), 4.26-4.24 (m, 1H), 4.12 (ddd, J = 11.8, 4.4, 2.7 Hz, 1H), 4.04 (ddd, J 
= 11.7, 5.1, 3.0 Hz, 1H), 2.79 (t, J = 2.5 Hz, 1H), 2.52 (ddd, J = 14.2, 6.3, 
3.8 Hz, 1H), 2.37-2.32 (m, 1H). 13C NMR (126 MHz, D2O) δ/ppm: 
158.57, 147.86, 142.14, 95.38, 87.99, 86.49, 86.41, 75.09, 73.79, 70.56, 64.29, 39.78, 33.51. 31P1H 
(202 MHz, D2O) δ/ppm: -0.04. MS (ESI) Calcd. for C12H17N3O7P+: M+, 346.1; found: 346.1. 
N3-(propargyl)-2′-deoxycytidine-5′-(O-propargyl)phosphate (61c). Yield 3 mg (0.008 mmol, 5 %). 
1H NMR (500 MHz, D2O) δ/ppm: 8.15 (d, J = 8.0 Hz, 1H), 6.35 (d, J = 
8.0 Hz, 1H), 6.24 (t, J = 6.4 Hz, 1H), 4.88 (dd, J = 2.6, 1.7 Hz, 2H), 
4.58-4.55 (m, 1H), 4.51 (dd, J = 10.2, 2.5 Hz, 2H), 4.28-4.26 (m, 1H), 
4.17 (ddd, J = 11.7, 4.3, 2.6 Hz, 1H), 4.09 (ddd, J = 11.7, 5.0, 3.1 Hz, 
1H), 2.91 (t, J = 2.4 Hz, 1H), 2.80 (t, J = 2.5 Hz, 1H), 2.54 (ddd, J = 
14.2, 6.3, 3.7 Hz, 1H), 2.38-2.33 (m, 1H). 13C NMR (126 MHz, D2O) δ/ppm: 158.56, 147.83, 142.14, 
95.34, 88.12, 86.40, 86.31, 75.80, 75.14, 73.79, 70.62, 64.80, 53.66, 53.60, 39.80, 33.53. 31P1H (202 
MHz, D2O) δ/ppm: -0.02. MS (ESI) Calcd. for C15H19N3O7P+: M+, 384.1; found: 384.2. 
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N3-((2-Hydroxyethyl)-1H-1,2,3-triazol-4-yl)methyl-2′-deoxycytidine-5′-monophosphate (61d). An 
NMR sample from compound 61b in D2O (600 l) was mixed with 
2-azidoethan-1-ol (5 l), 12.5 mM CuSO4 in D2O (24 l), and 100 
mM sodium ascorbate in D2O (30 l). 1H NMR after 5 min at room 
temperature showed complete disappearance of the resonance for 
the terminal alkyne proton. The whole mixture was purified by 
preparative HPLC. 1H NMR (500 MHz, D2O) δ/ppm: 8.21 (d, J = 8.0 Hz, 1H), 6.36 (d, J = 8.0 Hz, 
1H), 6.24 (t, J = 6.3 Hz, 1H), 5.35 (s, 2H), 4.54-4.52 (m, 3H), 4.25-4.23 (m, 1H), 4.11 (ddd, J = 11.7, 
4.2, 2.6 Hz, 1H), 4.03 (ddd, J = 11.7, 5.2, 3.1 Hz, 1H), 3.98-3.96 (m, 2H), 2.51 (ddd, J = 14.2, 6.3, 3.9 
Hz, 1H), 2.37-2.32 (m, 1H). 13C NMR (determined from 1H-13C HMQC and 1H-13C HMBC, D2O) 
δ/ppm: 159.14, 148.18, 142.30, 139.49, 125.40, 95.29, 87.88, 86.41, 70.50, 64.16, 59.94, 52.52, 39.68, 
39.00. 31P1H (202 MHz, D2O) δ/ppm: 0.17. MS (ESI) Calcd. for C14H22N6O8P+: M+H+, 433.1; 
found: 434.2. 
5.4. Oligonucleotide synthesis and purification 
Solid-phase oligonucleotide synthesis was carried out on 1-mol CPG columns using standard 
phosphoramidite chemistry with 0.3 M 5-benzylthio-1-H-tetrazole as activator. The DNA 
oligonucleotides were cleaved from the support with 32 % (v/v) aqueous ammonia for 2 h at room 
temperature and deprotected for 18 h at 55 C, then freeze-dried and purified by micropreparative 
HPLC using method A or by semi-prepeparative HPLC.  
The RNA oligonucleotides were synthesized using TBDMS protection strategy for the 2-OH group. 
Cleavage from the support was done in 32 % aqueous ammonia/ethanol 3:1 (v/v) for 2 h at room 
temperature followed by deprotection for 12 h at 55 C. The samples were freeze-dried and the 
TBDMS groups were cleaved with triethylamine/triethylamine trihydrofluoride/N-methylpyrrolidine 
1.5:2:3 (v/v/v) for 2 h at 65 °C. The crude oligoribonucleotides were isolated by precipitation with 3 
M NaOAc (1/10 volume) and n-butanol (4 volumes) for 2 h at -78 °C followed by centrifugation 
(15,000 × g, 10 min). The pellets were washed with 70 % (v/v) ethanol and dried under high vacuum. 
The samples were further purified by micropreparative HPLC using method A.  
The identity of all synthesized oligonucleotides was confirmed by ESI MS or MALDI TOF. 
 
5.5. Nucleic acid alkylation with rhodium(II) carbenoids 
General procedure for Rh2(OAc)4-catalyzed oligonucleotide modification using -diazocarbonyl 
compounds. Typically 10 or 20 l reaction mixtures containing 5 mM oligonucleotide, 500 M 
Rh2(OAc)4 and 50 mM  -diazocarbonyl compound in 100 mM MES buffer, pH 6.0 were kept at 20 
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C for 24-72 h. Analysis of the reaction products was carried out by micropreparative HPLC-
separation of 5-l aliquots of the reaction mixtures using method A. The collected peak fractions were 
further assessed by ESI-MS or MALDI TOF. 
 
 
 
Figure E3│HPLC trace of the modification reaction of d(A4) with Dz1 (HPLC analysis by method A). 
 
 
 
 
Figure E4│HPLC trace of the modification reaction of d(C4) with Dz1 (HPLC analysis by method A). 
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Figure E5│HPLC trace of the modification reaction of a mixture of r(ACU GCU) with Dz1 (HPLC analysis by 
method A). 
 
 
Figure E6│HPLC trace of the modification reaction of d(ACT GCT) with Dz1 (HPLC analysis by method A). 
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Figure E7│HPLC trace of the modification reaction of d(CTC TCT) with Dz1 (HPLC analysis by method A). 
 
 
 
 
Figure E8│HPLC trace of the modification reaction of d(CTG GCT) with Dz1 (HPLC analysis by method A). 
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Figure E10│HPLC trace of the modification reaction of d(TTT ATT TGT TTC TTT) with Dz1 (HPLC analysis 
by method A). 
 
 
 
Figure E11│HPLC trace of the modification reaction of d(CGA ACG TTT TTC GTT CGA) (hairpin DNA 
oligonucleotide with a 3-adenine overhang) with Dz1 (HPLC analysis by method A). 
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Figure E12│MALDI TOF MS spectrum of the main peak fraction of the modification reaction of d(TTT ATT 
TGT TTC TTT) with Dz5.  
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Figure E13│MALDI TOF MS spectrum of the ‘click’ products of the propargylated d(TTT ATT TGT TTC 
TTT) with (a) Rhodamine B azide and (b) biotin azide. 
 
 
Figure E14│MALDI TOF MS of the singly (a) and doubly (b) propargylated d(C4)-T7 promoter primer and the 
‘click’ reaction products of the total propargylated fraction with Rhodamine B azide (c). 
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5.5.1. NMR Characterization of d(TCT), d (TAT) and d(TGT) and the products of alkylation 
with Dz1 
All measurements were performed on a Bruker Avance III NMR spectrometer (600.13 MHz proton 
frequency) equipped with a 5-mm BBFO smart probe with shielded z-gradient coil. All measurements 
were carried out at 298 K in Shigemi Microcell NMR tubes (280 l sample volume).  
The HPLC-purified oligonucleotide was dissolved in 300 l of 10 mM potassium phosphate buffer, 
pH 6.0, containing 5 % (v/v) D2O. The pH was then adjusted to 6.00 with dilute HCl and NaOH. For 
water suppression, an excitation sculpting pulse sequence was used.103 For experiments in D2O, the 
sample was freeze-dried from the H2O-containing phosphate buffer, re-dissolved in 100 l of D2O, 
freeze-dried again and then dissolved in D2O (99.99 %, Aldrich). It was then used directly without 
further adjustment of the pH.    
The unambiguous assignment of the proton, carbon and phosphorous resonances was performed using 
standard COSY, long range - COSY, TOCSY, ROESY, HMQC, 1H-13C HMBC and 1H-31P-HMBC 
experiments. 
 
 
5.6. Nucleic acid alkylation with copper(I) carbenoids 
General procedure for Cu(I)-catalyzed oligonucleotide modification using -diazocarbonyl 
compounds. Typically 10 or 20 l reaction mixtures containing 5 mM oligonucleotide, 500 M 
CuSO4, 2.5 mM THPTA and 50 mM  -diazocarbonyl compound, and 10 mM sodium ascorbate in 
100 mM MES buffer, pH 6.0 were kept at 20 C for 24-72 h. Analysis of the reaction products was 
carried out by micropreparative HPLC-separation of 5-l aliquots of the reaction mixtures using 
methods A or C. The analysis of the modification reactions of d(ATG C) and d(ATG) was done in two 
different buffer systems (methods C and D) in order to fully resolve some of the modification products 
from the unreacted diazo substrate. The collected peak fractions were further assessed by ESI-MS or 
MALDI TOF. The designations of the chromatographic peak fractions (Supplementary Figures S1, 3, 
6, 8-16) indicate the molecular mass of the species, and the number of alkylations per molecule of 
oligonucleotide (in parenthesis) 
The singly charged ions of the modified products of the three trimers d(TAT), d(TGT) and d(TCT) 
from the ESI-MS were subjected to tandem mass spectrometry. 
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Figure E15│HPLC traces of the screening for metal catalyst for ON alkylation using method C (see Table 4). 
(a) Starting oligonucleotide (b) Modified products (c) Non-converted diazo substrate. 
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Figure E16│HPLC trace of the modification reaction of a d(TAT) with Dz1 (HPLC analysis by method C). The 
peak labels refer to the masses observed in the ESI-MS for those peaks. The (+1), (+2), or (+3) label indicates 
singly-, doubly-, or triply alkylated products. 
 
 
 
 
Figure E17│ESI-MS (A) and MS/MS analysis (B) of the singly-modified d(TAT) with Dz1.  
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Figure E18│ESI-MS (A, C) and MS/MS analysis (B, D) of the singly-modified d(TGT) with Dz1. 
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Figure E19│ESI-MS (A) and MS/MS analysis (B) of the doubly-modified d(TGT) with Dz1. 
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Figure E20│ESI-MS (A) and MS/MS analysis (B, C) of the singly-modified d(TCT) with Dz1. 
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Figure E21│ESI-MS of singly (A), doubly (B) and triply modified (C) d(ATG C) with Dz1. 
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Figure E22│HPLC trace of the modification reaction of d(T4) with Dz1 (HPLC analysis by method C). The 
peak labels refer to the masses observed in the ESI-MS for those peaks. The (+1), (+2), or (+3) label indicates 
singly-, doubly-, or triply alkylated products. 
 
 
 
 
 
Figure E23│ESI-MS of singly modified d(T4) with Dz1. 
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Figure E24│ HPLC trace of the modification reaction of d(ATG) with Dz1 (HPLC analysis by method C). The 
peak labels refer to the masses observed in the ESI-MS for those peaks. The (+1), (+2), or (+3) label indicates 
singly-, doubly-, or triply alkylated products. 
 
 
Figure E25│ HPLC trace of the modification reaction of a d(ATG) with Dz1 (HPLC analysis by method D). 
The peak labels refer to the masses observed in the ESI-MS for those peaks. The (+1), (+2), or (+3) label 
indicates singly-, doubly-, or triply alkylated products. 
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Figure E26│ESI-MS of singly (A), doubly (B) and triply modified (C) d(ATG) with Dz1. The doubly and triply 
modified species were observed as triethylammonium adducts. 
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Figure E27│ HPLC trace of the modification reaction of r(ACU GCU C) with Dz1 (HPLC analysis by method 
E). The peak labels refer to the masses observed in the ESI-MS for those peaks. The (+1), (+2), or (+3) label 
indicates singly-, doubly-, or triply alkylated products. 
 
 
 
 
 
 
Figure E28│ESI-MS of singly modified r(ACU GCU C) with Dz-1. 
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5.6.1. Cu(I)-catalyzed oligonucleotide modification using -diazocarbonyl compounds in the 
presence of proteins.  
Protein concentration was determined from the absorbance at 279 or 280 nm using the following 
extinction coefficients: 43 824 M-1cm-1 for bovine serum albumin,104 38 940 M-1cm-1 for lysozyme,105 
and 41 820 M-1cm-1 for streptavidine.106  Typically 20 l reaction mixtures containing 5 mM d(TAT), 
1 mM protein of interest, 500 M CuSO4, 2.5 mM THPTA, 50 mM  -diazocarbonyl compound, and 
10 mM sodium ascorbate in 100 mM MES buffer, pH 6.0 were kept at 20 C for 24 h. Analysis of the 
reaction products was carried out by HPLC using method A. Aliquots (5-l) of the reaction mixtures 
were then separated micropreparatively and the collected peak fractions were further assessed by ESI-
MS. The effect of the protein on the modification reaction was estimated by comparison of the 
conversion of the oligonucleotide and the diazo substrate in the presence of protein in a control 
sample. 
 
 
5.6.2. Auto-catalytic tandem CuAAC/N-H insertion with nucleic acids 
Tandem alkylation/click reaction using diazo compound 57 and 3-azidoprop-1-ol. Typically 10 or 
20 l reaction mixtures containing 5 mM oligonucleotide, 500 M CuSO4, 2.5 mM THPTA, 50 mM 
compound 57, 55 mM of the azide and 10 mM sodium ascorbate  in 100 mM MES buffer, pH 6.0 
were kept at 20 C for 24 h. Analysis of the reaction products was carried out by micropreparative 
HPLC-separation of 5-l aliquots of the reaction mixtures using method C. The collected peak 
fractions were further assessed by ESI-MS or MALDI TOF. 
 
Tandem alkylation/click reaction using diazo compound 57 and 1-(2-azidoacetyl)-4-(D-
biotinyl)piperazine) 47. Typically 10 or 20 l reaction mixtures containing 2.5 mM oligonucleotide, 
250 M CuSO4, 1.25 mM THPTA, 25 mM propargyl-tagged -diazocarbonylcompound 57, 25 mM 
of the azide and 10 mM sodium ascorbate  in 100 mM MES buffer, pH 6.0 were kept at 20 C for 24 
h. Analysis of the reaction products was carried out by micropreparative HPLC-separation of 5-l 
aliquots of the reaction mixtures using method C. The collected peak fractions were further assessed 
by ESI-MS or MALDI TOF. 
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Figure E29│ESI-MS of +1Akl-Me (A), +1Alk/Click (B), +2Alk/Click (C), and +3Alk/Click (D) modified d(ATG) with 
diazo compound 57 and 3-azidoprop-1-ol. 
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Figure E30│ MALDI TOF of the products from the tandem alkylation/’click’ reaction of d(ATG C) with diazo 
compound 57 and 1-(2-azidoacetyl)-4-D-biotinylpiperazine (see Figure 24). 
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5.7. AlkB expression and purification 
5.7.1. General 
The restrictases XhoI and NdeI and T4 DNA ligase were from New England Biolabs, the restrictase 
EcoRI was from Roche. Kanamycin sulfate and IPTG were purchased from Fischer Biochemicals, 
Chloramphenicol was from Apollo. GenEluteTM Plasmid Miniprep Kit was from Sigma, NucleoSpin® 
Gel and PCR Clean-up Kit was from Macherey-Nagel.  
Protein SDS PAGE was carried out according to the method of Laemmli107 in a BioRad MiniProtean 
Tetra system. Staining was done with Coomassie Brilliant Blue, the molecular weight of the proteins 
was referenced to Precision Plus ProteinTM All Blue Standards (BioRad). DNA electrophoresis was 
done in a horizontal BioRad MiniSub Gel GT cell using 1 % (w/v) agarose (EEO-Mr < 0.15, Fischer 
Biochemicals) slabs and 1×TAE both for the gel and as electrode buffer. Bromphenol blue was used as 
a trace dye, visualization was done with ethidium bromide added to the gel slab. DNA size was 
referenced to 100 bp DNA ladder and 1 kb DNA ladder (New England Biolabs). Gel imaging was 
carried out on a BioRad Universal Hood III, equipped with Image Lab 5.0 software. 
Plasmid sequencing was done by Microsynth AG. 
 
Culture media  
LB: 10 g tryptone, 5 g yeast extract, 10 g NaCl, 1g agar (for solid media), water to 1000 ml. 
Modified SOC: tryptone 8 g, yeast extract 2 g, NaCl 0.2 g, KCl 0.19 g, water to 400 ml; after 
autoclaving sterile-filtered 1M glucose (8 ml) was added. 
Antibiotics were used in the following final concentrations: 50 g/ml for kanamycin (Kan) from a 
sterile-filtered 1000× in water; 34 g/ml for chloramphenicol (Cam) from a 1000× in ethanol. 
 
Buffers and solutions 
50×TAE: 242 g Tris Base, 57.1 ml acetic acid, 100 ml 0.5M EDTA, pH 8.0, water to 1000 ml 
IPTG – 200 mM in water, sterile-filtered 
Lysis buffer: 500 mM NaCl, 50 mM sodium phosphate buffer, pH 8.0 
Enzyme storage buffer: 300 mM NaCl, 2 mM DTT, 50 mM TrisHCl, pH 8.0 
 
Preparation of chemically competent E.coli cells 
Competent E.coli NEB10beta and LB21 cells were prepared by treatment with CaCl2 as follows. 
Single colonies were transferred in 3 ml LB and shaken overnight at 37°C. LB medium (100 ml) was 
inoculated with 1-ml of the overnight starter culture and grown at 37°C with shaking until OD600 0.40-
0.45 was reached. The cultures were then cooled in ice, centrifuged (3000×g, 10 min, 4°C), and the 
cell pellets were drained over paper and resuspended in 20 ml ice-cold sterile 100 mM CaCl2. The 
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suspensions were left for 30 min in ice, then centrifuged, and resuspended in 6 ml ice-cold sterile 100 
mM CaCl2, containing 15 % (v/v) glycerol. Fifty-microliter aliquots were then transferred to cold 1.5-
ml tubes, flash-frozen in liquid nitrogen and stored at -80°C. 
Heat shock transformation of chemically competent E.coli cells 
A fifty-microliter aliquot of the competent cells was mixed with plasmid DNA (10-100 ng) and left on 
ice for 30 min. The tubes were then incubated at 42°C for 1.5 min, and again on ice for 5 min. SOC 
medium (0.95 ml) was added to each tube, and the cultures were transferred into 15-ml sterile Falcon 
tubes and shaken at 37°C for one hour without addition of antibiotics. Aliquots (0.1 ml) were then 
plated on LB agar, containing the respective antibiotic for the selection, and the incubated overnight at 
37°C. Single colonies of the transformants were then picked and grown in LB medium with the 
respective antibiotic.   
5.7.2. Subcloning of the alkB gene from E.coli LB21     
The alkB gene was isolated from E.coli BL21 by colony PCR with Pfu+Taq polymerase mixture and 
the following thermocycler program min (°C): 5(95) ×1, 1(95), 1.5(54), 1(72) ×30, 10(72) ×1, 4(inf.). 
The following primers were used:  
- Forward primer: GGC AGC CAT ATG TTG GAT CTG TTT GCC GAT (Tm 64°C (basic), GC 
50%), contains restriction site for NdeI; 
- Reverse primer: GTG GTG CTC GAG TTA TTC TTT TTT ACC TGC (Tm 60°C (basic), GC 
43%), contains restriction site for XhoI. 
The PCR product was purified using the PCR purification kit (M.-N.), double digested with NdeI and 
XhoI according to the manufacturer’s instructions. A larger amount of NdeI was used to insure full 
digestion. The obtained insert was ligated in a pET-28a vector using T4 DNA ligase and 100 ng vector 
in ratios vector to insert 1:3 and 1:6. Chemically competent E.coli NEB10beta cells (50 l aliquots) 
were transformed with aliquots from the ligation mixtures (4 l) and plated for selection on LB agar 
with Kan. Single colonies of the transformants were picked and grown in 10-ml LB medium with 
kanamycin for plasmid DNA isolation. The correct transformants were identified by restriction 
analysis and sequencing of the isolated plasmid DNA. 
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Sequencing of the vector with the cloned insert (PCR-based sequencing with T7 promoter 
primer. The sequence for the N-terminal His6-tag is shown in grey) 
CTAGAAANATTTTGTTTACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATC
ATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGTTGGATCTGTTTGCCGATG
GTGAACCGTGGCAAGAGCCACTGGCGGCTGGAGCGGTAATTTTACGGCGTTTTGCTTTTA
ACGCTGCGGAGCAACTAATCCGCGATATTAATGACGTTGCCAGCCAGTCGCCGTTTCGCC
AGATGGTCACCCCCGGGGGATATACCATGTCGGTGGCGATGACCAACTGTGGGCATCTGG
GCTGGACGAGCCATCGGCAAGGTTATCTCTATTCGCCCATTGATCCGCAAACAAATAAAC
CGTGGCCCGCCATGCCACAGAGTTTTCATAATTTATGTCAACGTGCGGCTACGGCGGCGG
GCTATCCAGATTTCCAGCCAGATGCTTGTCTTATCAACCGCTACGCTCCTGGCGCGAAACT
GTCGCTGCATCAGGATAAAGACGAACCGGATCTGCGCGCGCCAATTGTTTCTGTTTCTCT
GGGCTTACCCGCGATTTTTCAATTTGGCGGCCTGAAACGTAATGATCCGCTCAAACGTTTG
TTGTTGGAACATGGCGATGTGGTGGTATGGGGCGGTGAATCGCGGCTGTTTTATCACGGT
ATTCAACCGTTGAAAGCGGGGTTTCATCCACTCACCACCGACTGCCGCTACAACCTGACA
TTCCGTCAGGCAGGTAAAAAAGAATAACTCGAGCACCACCACCACCACCACTGAGATCC
GGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAAC
TAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAA
CTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGT
GGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGC
TTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGC
TCCCTTTAGGNTTCCGATTNANNNNNTTACGGNNCCTCGACCCCAAAAACTTGATTAGGN
NGA 
        
Theoretical size of the insert containing the alkB gene after double digestion: 655 bp 
 
Figure E31│ Agarose gel electrophoresis of the plasmid preparation from E.coli NEB10beta with restriction analysis (left), 
and map of the construct pET28a-alkB depicting the cloned insert (right). The construct map was prepared using SnapGene 
software. 
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Expression product from the first reading frame (236 amino acids, theoretical MW 26198.74, in-
frame with the His6-tag) 
 
        10         20         30         40         50         60  
MGSSHHHHHH SSGLVPRGSH MLDLFADGEP WQEPLAAGAV ILRRFAFNAA EQLIRDINDV  
 
        70         80         90        100        110        120  
ASQSPFRQMV TPGGYTMSVA MTNCGHLGWT SHRQGYLYSP IDPQTNKPWP AMPQSFHNLC  
 
       130        140        150        160        170        180  
QRAATAAGYP DFQPDACLIN RYAPGAKLSL HQDKDEPDLR APIVSVSLGL PAIFQFGGLK  
 
       190        200        210        220        230  
RNDPLKRLLL EHGDVVVWGG ESRLFYHGIQ PLKAGFHPLT TDCRYNLTFR QAGKKE  
 
 
5.7.3. AlkB overexpression and purification     
Competent E.coli BL21 (50 l aliquots) were transformed with the pET28a-alkB construct from 5.7.2 
(50-100 ng per aliquot) by heat shock, then plated for selection on LB-agar+Kan+Cam. Single 
colonies were picked, transferred to 10 ml LB+Kan+Cam in 50 ml sterile Falcon tubes and grown 
overnight at room temperature. LB medium (1000 ml) was inoculated with 10 ml of the overnight 
starter culture and grown at 37°C until OD600 of 0.7-0.8. The cultures were then briefly cooled in ice 
and induced with IPTG in a final concentration of 0.2 mM overnight at 18°C. The cells were harvested 
by centrifugation (3000×g, 20 min, 4°C), the cell pellets were resuspended in lysis buffer (1:5 v/v) and 
lysed by sonication. The cell lysates were clarified by centrifugation (4000×g, 20 min, 4°C), then 
mixed with Ni-NTA pre-washed with lysis buffer (ca. 0.1 ml of resin per liter of culture medium) and 
left for 20 min in ice with occasional swirling. The mixtures were then filtered on disposable plastic 
columns. The resin was washed with lysis buffer until A280 of the effluent was smaller than 0.05, then 
with 10, 20, and 40 mM imidazole in lysis buffer (1 ml of each per 0.1 ml of resin). The target protein 
was eluted with 250 mM imidazole in lysis buffer (4 × 0.3 ml). The purity of the elution fractions was 
checked by SDS PAGE in 12.5 % resolving gel. After that the appropriate fractions were pooled, 
concentrated on a 3kD centrifuged filter (Amicon), and washed twice with ten volumes of enzyme 
storage buffer. Glycerol was then added to a final concentration of 50 % (v/v) from an 80 % (v/v) 
stock in water, and the preparations were stored at -20°C. 
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Figure E32│ SDS PAGE analysis of the AlkB protein. Lane 1: clarified lysate, lane 2: flow through from loading the 
clarified lysate on the Ni-NTA resin, lanes 3 to 5: fractions from elution with 250 mM imidazole, M – molecular weight 
markers. The molecular weight of the standards are shown on the right. 
 
5.7.4. Determination of delakylation activity 
Reaction mixtures (50 l) with the following content were prepared: 1 mM alkylated nucleoside 
monophosphate, 2 mM -ketoglutarate, 100 M FeSO4, 2 mM sodium ascorbate, 2 mM DTT, 50 mM 
KCl, 100 g.ml-1 BSA, 50 mM Tris-HCl, pH 8.0, and 7.44 M AlkB. The mixtures were incubated at 
37°C. Ten microliter aliquots were withdrawn at specific time intervals and mixed with 1 l 500 mM 
EDTA, pH 8.0, then analyzed by analytical RP-HPLC using method F. All reactions were done in 
duplicate together with control samples without enzyme. The reaction rates were determined from the 
disappearance of the nucleoside substrate or the accumulation of the repaired product, calculated from 
the peak areas in the HPLC-traces. 
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